negative regulation of protein catabolic process (GO:0042177),1,1,0.18,+,5.44,1.68E-01
protein K63-linked deubiquitination (GO:0070536),1,1,0.18,+,5.44,1.68E-01
peptidyl-tyrosine dephosphorylation (GO:0035335),1,1,0.18,+,5.44,1.68E-01
embryo development ending in birth or egg hatching (GO:0009792),1,1,0.18,+,5.44,1.68E-01
protein localization to kinetochore (GO:0034501),1,1,0.18,+,5.44,1.68E-01
nucleotide-sugar transmembrane transport (GO:0015780),1,1,0.18,+,5.44,1.68E-01
citrate transport (GO:0015746),1,1,0.18,+,5.44,1.68E-01
protein insertion into mitochondrial inner membrane (GO:0045039),1,1,0.18,+,5.44,1.68E-01
endoderm development (GO:0007492),2,2,0.37,+,5.44,5.30E-02
L-alpha-amino acid transmembrane transport (GO:1902475),2,2,0.37,+,5.44,5.30E-02
mitochondrial outer membrane translocase complex assembly (GO:0070096),1,1,0.18,+,5.44,1.68E-01
heart morphogenesis (GO:0003007),1,1,0.18,+,5.44,1.68E-01
response to molecule of bacterial origin (GO:0002237),1,1,0.18,+,5.44,1.68E-01
chordate embryonic development (GO:0043009),1,1,0.18,+,5.44,1.68E-01
ectoderm development (GO:0007398),2,2,0.37,+,5.44,5.30E-02
response to lipopolysaccharide (GO:0032496),1,1,0.18,+,5.44,1.68E-01
gastrulation (GO:0007369),2,2,0.37,+,5.44,5.30E-02
negative regulation of protein ubiquitination (GO:0031397),1,1,0.18,+,5.44,1.68E-01
mesoderm formation (GO:0001707),2,2,0.37,+,5.44,5.30E-02
endoderm formation (GO:0001706),2,2,0.37,+,5.44,5.30E-02
ectoderm formation (GO:0001705),2,2,0.37,+,5.44,5.30E-02
formation of primary germ layer (GO:0001704),2,2,0.37,+,5.44,5.30E-02
carbohydrate derivative transport (GO:1901264),1,1,0.18,+,5.44,1.68E-01
pyrimidine nucleotide-sugar transmembrane transport (GO:0090481),1,1,0.18,+,5.44,1.68E-01
secondary alcohol metabolic process (GO:1902652),1,1,0.18,+,5.44,1.68E-01
fatty acid derivative metabolic process (GO:1901568),1,1,0.18,+,5.44,1.68E-01
behavior (GO:0007610),1,1,0.18,+,5.44,1.68E-01
positive regulation of Ras protein signal transduction (GO:0046579),2,2,0.37,+,5.44,5.30E-02
L-amino acid transport (GO:0015807),2,2,0.37,+,5.44,5.30E-02
basic amino acid transport (GO:0015802),1,1,0.18,+,5.44,1.68E-01
C4-dicarboxylate transport (GO:0015740),3,3,0.55,+,5.44,1.85E-02
triglyceride biosynthetic process (GO:0019432),3,3,0.55,+,5.44,1.85E-02
dicarboxylic acid transport (GO:0006835),3,3,0.55,+,5.44,1.85E-02
nucleoside diphosphate metabolic process (GO:0009132),9,8,1.65,+,4.84,3.19E-04
ribonucleoside diphosphate metabolic process (GO:0009185),8,7,1.47,+,4.76,8.15E-04
purine ribonucleoside diphosphate metabolic process (GO:0009179),8,7,1.47,+,4.76,8.15E-04
purine nucleoside diphosphate metabolic process (GO:0009135),8,7,1.47,+,4.76,8.15E-04
nucleoside diphosphate phosphorylation (GO:0006165),8,7,1.47,+,4.76,8.15E-04
ATP generation from ADP (GO:0006757),8,7,1.47,+,4.76,8.15E-04
glycolytic process (GO:0006096),8,7,1.47,+,4.76,8.15E-04
ADP metabolic process (GO:0046031),8,7,1.47,+,4.76,8.15E-04
nucleotide phosphorylation (GO:0046939),8,7,1.47,+,4.76,8.15E-04
"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",4,3,0.74,+,4.08,3.85E-02
regulation of circadian rhythm (GO:0042752),4,3,0.74,+,4.08,3.85E-02
circadian regulation of gene expression (GO:0032922),4,3,0.74,+,4.08,3.85E-02
rhythmic process (GO:0048511),8,6,1.47,+,4.08,4.02E-03
circadian rhythm (GO:0007623),8,6,1.47,+,4.08,4.02E-03
regulation of G protein-coupled receptor signaling pathway (GO:0008277),3,2,0.55,+,3.63,1.06E-01
negative regulation of MAPK cascade (GO:0043409),3,2,0.55,+,3.63,1.06E-01
regulation of mitochondrion organization (GO:0010821),3,2,0.55,+,3.63,1.06E-01
acyl-CoA metabolic process (GO:0006637),3,2,0.55,+,3.63,1.06E-01
Golgi to plasma membrane protein transport (GO:0043001),3,2,0.55,+,3.63,1.06E-01
regulation of double-strand break repair (GO:2000779),3,2,0.55,+,3.63,1.06E-01
pyrimidine nucleobase metabolic process (GO:0006206),3,2,0.55,+,3.63,1.06E-01
establishment or maintenance of bipolar cell polarity (GO:0061245),5,3,0.92,+,3.26,6.59E-02
triglyceride metabolic process (GO:0006641),5,3,0.92,+,3.26,6.59E-02
organic acid transmembrane transport (GO:1903825),10,6,1.84,+,3.26,1.13E-02
cellular response to light stimulus (GO:0071482),5,3,0.92,+,3.26,6.59E-02
carboxylic acid transmembrane transport (GO:1905039),10,6,1.84,+,3.26,1.13E-02
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),5,3,0.92,+,3.26,6.59E-02
membrane protein ectodomain proteolysis (GO:0006509),5,3,0.92,+,3.26,6.59E-02
amino acid transport (GO:0006865),10,6,1.84,+,3.26,1.13E-02
establishment or maintenance of apical/basal cell polarity (GO:0035088),5,3,0.92,+,3.26,6.59E-02
amino acid transmembrane transport (GO:0003333),7,4,1.29,+,3.11,4.17E-02
maturation of LSU-rRNA (GO:0000470),13,7,2.39,+,2.93,1.12E-02
carboxylic acid transport (GO:0046942),15,8,2.76,+,2.9,7.36E-03
organic acid transport (GO:0015849),15,8,2.76,+,2.9,7.36E-03
establishment of protein localization to membrane (GO:0090150),25,13,4.59,+,2.83,9.39E-04
regulation of peptide secretion (GO:0002791),2,1,0.37,+,2.72,3.08E-01
long-chain fatty acid metabolic process (GO:0001676),2,1,0.37,+,2.72,3.08E-01
"vacuole fusion, non-autophagic (GO:0042144)",2,1,0.37,+,2.72,3.08E-01
positive regulation of cell death (GO:0010942),2,1,0.37,+,2.72,3.08E-01
iron-sulfur cluster assembly (GO:0016226),4,2,0.74,+,2.72,1.68E-01
chondroitin sulfate proteoglycan metabolic process (GO:0050654),2,1,0.37,+,2.72,3.08E-01
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),2,1,0.37,+,2.72,3.08E-01
tRNA wobble uridine modification (GO:0002098),2,1,0.37,+,2.72,3.08E-01
neuromuscular junction development (GO:0007528),2,1,0.37,+,2.72,3.08E-01
attachment of spindle microtubules to kinetochore (GO:0008608),2,1,0.37,+,2.72,3.08E-01
mesoderm morphogenesis (GO:0048332),4,2,0.74,+,2.72,1.68E-01
actin cytoskeleton reorganization (GO:0031532),2,1,0.37,+,2.72,3.08E-01
mitotic spindle assembly (GO:0090307),2,1,0.37,+,2.72,3.08E-01
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",8,4,1.47,+,2.72,6.18E-02
rRNA base methylation (GO:0070475),2,1,0.37,+,2.72,3.08E-01
negative regulation of transport (GO:0051051),2,1,0.37,+,2.72,3.08E-01
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),2,1,0.37,+,2.72,3.08E-01
receptor clustering (GO:0043113),4,2,0.74,+,2.72,1.68E-01
insulin receptor signaling pathway (GO:0008286),2,1,0.37,+,2.72,3.08E-01
pseudouridine synthesis (GO:0001522),4,2,0.74,+,2.72,1.68E-01
response to peptide hormone (GO:0043434),4,2,0.74,+,2.72,1.68E-01
attachment of mitotic spindle microtubules to kinetochore (GO:0051315),2,1,0.37,+,2.72,3.08E-01
metaphase plate congression (GO:0051310),2,1,0.37,+,2.72,3.08E-01
mesoderm development (GO:0007498),4,2,0.74,+,2.72,1.68E-01
negative regulation of MAP kinase activity (GO:0043407),2,1,0.37,+,2.72,3.08E-01
DNA double-strand break processing (GO:0000729),2,1,0.37,+,2.72,3.08E-01
regulation of telomere maintenance (GO:0032204),2,1,0.37,+,2.72,3.08E-01
response to lipid (GO:0033993),2,1,0.37,+,2.72,3.08E-01
mitochondrial translation (GO:0032543),10,5,1.84,+,2.72,3.91E-02
cell adhesion mediated by integrin (GO:0033627),2,1,0.37,+,2.72,3.08E-01
membrane protein proteolysis (GO:0033619),8,4,1.47,+,2.72,6.18E-02
mitochondrial cytochrome c oxidase assembly (GO:0033617),2,1,0.37,+,2.72,3.08E-01
cellular response to peptide (GO:1901653),4,2,0.74,+,2.72,1.68E-01
response to peptide (GO:1901652),4,2,0.74,+,2.72,1.68E-01
vacuolar protein processing (GO:0006624),2,1,0.37,+,2.72,3.08E-01
protein targeting to membrane (GO:0006612),20,10,3.68,+,2.72,4.56E-03
positive regulation of programmed cell death (GO:0043068),2,1,0.37,+,2.72,3.08E-01
positive regulation of apoptotic process (GO:0043065),2,1,0.37,+,2.72,3.08E-01
mitotic metaphase plate congression (GO:0007080),2,1,0.37,+,2.72,3.08E-01
protein insertion into membrane (GO:0051205),2,1,0.37,+,2.72,3.08E-01
protein localization to synapse (GO:0035418),4,2,0.74,+,2.72,1.68E-01
negative regulation of catabolic process (GO:0009895),2,1,0.37,+,2.72,3.08E-01
histone H4-K16 acetylation (GO:0043984),4,2,0.74,+,2.72,1.68E-01
negative regulation of cellular catabolic process (GO:0031330),2,1,0.37,+,2.72,3.08E-01
intrinsic apoptotic signaling pathway (GO:0097193),4,2,0.74,+,2.72,1.68E-01
regulation of protein secretion (GO:0050708),2,1,0.37,+,2.72,3.08E-01
arginine catabolic process (GO:0006527),2,1,0.37,+,2.72,3.08E-01
cellular response to peptide hormone stimulus (GO:0071375),4,2,0.74,+,2.72,1.68E-01
GPI anchor biosynthetic process (GO:0006506),4,2,0.74,+,2.72,1.68E-01
GPI anchor metabolic process (GO:0006505),4,2,0.74,+,2.72,1.68E-01
receptor localization to synapse (GO:0097120),4,2,0.74,+,2.72,1.68E-01
actin filament bundle organization (GO:0061572),6,3,1.1,+,2.72,1.00E-01
protein K63-linked ubiquitination (GO:0070534),6,3,1.1,+,2.72,1.00E-01
cytochrome complex assembly (GO:0017004),6,3,1.1,+,2.72,1.00E-01
anatomical structure formation involved in morphogenesis (GO:0048646),12,6,2.21,+,2.72,2.50E-02
actin filament bundle assembly (GO:0051017),6,3,1.1,+,2.72,1.00E-01
cytoplasmic mRNA processing body assembly (GO:0033962),6,3,1.1,+,2.72,1.00E-01
Golgi to vacuole transport (GO:0006896),6,3,1.1,+,2.72,1.00E-01
glycerolipid biosynthetic process (GO:0045017),13,6,2.39,+,2.51,3.48E-02
ribosomal large subunit biogenesis (GO:0042273),33,15,6.06,+,2.47,1.50E-03
rRNA modification (GO:0000154),9,4,1.65,+,2.42,8.63E-02
organic anion transport (GO:0015711),30,13,5.51,+,2.36,4.43E-03
regulation of cell shape (GO:0008360),7,3,1.29,+,2.33,1.40E-01
phospholipid biosynthetic process (GO:0008654),14,6,2.57,+,2.33,4.69E-02
inositol lipid-mediated signaling (GO:0048017),7,3,1.29,+,2.33,1.40E-01
phosphatidylinositol-mediated signaling (GO:0048015),7,3,1.29,+,2.33,1.40E-01
regulation of sodium ion transport (GO:0002028),7,3,1.29,+,2.33,1.40E-01
cellular amino acid catabolic process (GO:0009063),14,6,2.57,+,2.33,4.69E-02
multicellular organism reproduction (GO:0032504),14,6,2.57,+,2.33,4.69E-02
acylglycerol metabolic process (GO:0006639),7,3,1.29,+,2.33,1.40E-01
neutral lipid metabolic process (GO:0006638),7,3,1.29,+,2.33,1.40E-01
protein localization to membrane (GO:0072657),45,19,8.27,+,2.3,9.05E-04
carbohydrate catabolic process (GO:0016052),19,8,3.49,+,2.29,2.62E-02
response to light stimulus (GO:0009416),12,5,2.21,+,2.27,7.29E-02
rRNA processing (GO:0006364),48,20,8.82,+,2.27,7.89E-04
rRNA metabolic process (GO:0016072),54,22,9.92,+,2.22,5.94E-04
regulation of meiotic cell cycle (GO:0051445),5,2,0.92,+,2.18,2.34E-01
negative regulation of protein phosphorylation (GO:0001933),5,2,0.92,+,2.18,2.34E-01
proteoglycan biosynthetic process (GO:0030166),5,2,0.92,+,2.18,2.34E-01
"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",5,2,0.92,+,2.18,2.34E-01
negative regulation of phosphorylation (GO:0042326),5,2,0.92,+,2.18,2.34E-01
regulation of MAP kinase activity (GO:0043405),10,4,1.84,+,2.18,1.15E-01
proteoglycan metabolic process (GO:0006029),5,2,0.92,+,2.18,2.34E-01
glucose metabolic process (GO:0006006),10,4,1.84,+,2.18,1.15E-01
liposaccharide metabolic process (GO:1903509),5,2,0.92,+,2.18,2.34E-01
protein localization to cell junction (GO:1902414),5,2,0.92,+,2.18,2.34E-01
glycolipid metabolic process (GO:0006664),5,2,0.92,+,2.18,2.34E-01
pyrimidine-containing compound metabolic process (GO:0072527),5,2,0.92,+,2.18,2.34E-01
anion transmembrane transport (GO:0098656),20,8,3.68,+,2.18,3.39E-02
glycolipid biosynthetic process (GO:0009247),5,2,0.92,+,2.18,2.34E-01
regulation of histone modification (GO:0031056),5,2,0.92,+,2.18,2.34E-01
dendrite development (GO:0016358),5,2,0.92,+,2.18,2.34E-01
regulation of DNA repair (GO:0006282),5,2,0.92,+,2.18,2.34E-01
mitochondrial membrane organization (GO:0007006),5,2,0.92,+,2.18,2.34E-01
pyrimidine nucleotide biosynthetic process (GO:0006221),5,2,0.92,+,2.18,2.34E-01
pyrimidine nucleotide metabolic process (GO:0006220),5,2,0.92,+,2.18,2.34E-01
apoptotic signaling pathway (GO:0097190),5,2,0.92,+,2.18,2.34E-01
establishment or maintenance of cell polarity (GO:0007163),18,7,3.31,+,2.12,5.12E-02
ribosome biogenesis (GO:0042254),85,32,15.62,+,2.05,1.62E-04
positive regulation of cellular amide metabolic process (GO:0034250),8,3,1.47,+,2.04,1.84E-01
positive regulation of protein serine/threonine kinase activity (GO:0071902),8,3,1.47,+,2.04,1.84E-01
protein palmitoylation (GO:0018345),8,3,1.47,+,2.04,1.84E-01
phosphatidylinositol biosynthetic process (GO:0006661),8,3,1.47,+,2.04,1.84E-01
negative regulation of protein modification process (GO:0031400),8,3,1.47,+,2.04,1.84E-01
post-Golgi vesicle-mediated transport (GO:0006892),16,6,2.94,+,2.04,7.78E-02
regulation of MAPK cascade (GO:0043408),19,7,3.49,+,2,6.43E-02
oxidation-reduction process (GO:0055114),63,23,11.58,+,1.99,1.86E-03
mitochondrial transmembrane transport (GO:1990542),22,8,4.04,+,1.98,5.34E-02
establishment of protein localization to peroxisome (GO:0072663),11,4,2.02,+,1.98,1.47E-01
protein localization to peroxisome (GO:0072662),11,4,2.02,+,1.98,1.47E-01
ATP metabolic process (GO:0046034),44,16,8.09,+,1.98,8.79E-03
protein targeting to peroxisome (GO:0006625),11,4,2.02,+,1.98,1.47E-01
endoplasmic reticulum unfolded protein response (GO:0030968),11,4,2.02,+,1.98,1.47E-01
sulfur compound metabolic process (GO:0006790),47,17,8.64,+,1.97,7.43E-03
mitochondrial transport (GO:0006839),25,9,4.59,+,1.96,4.44E-02
mitochondrial gene expression (GO:0140053),14,5,2.57,+,1.94,1.19E-01
generation of precursor metabolites and energy (GO:0006091),56,20,10.29,+,1.94,4.50E-03
glutathione metabolic process (GO:0006749),31,11,5.7,+,1.93,3.10E-02
positive regulation of intracellular signal transduction (GO:1902533),20,7,3.68,+,1.9,7.93E-02
ribosomal small subunit biogenesis (GO:0042274),26,9,4.78,+,1.88,5.42E-02
lipoprotein biosynthetic process (GO:0042158),18,6,3.31,+,1.81,1.18E-01
regulation of cytosolic calcium ion concentration (GO:0051480),9,3,1.65,+,1.81,2.31E-01
negative regulation of nuclear division (GO:0051784),9,3,1.65,+,1.81,2.31E-01
mitochondrial respiratory chain complex assembly (GO:0033108),9,3,1.65,+,1.81,2.31E-01
protein lipidation (GO:0006497),18,6,3.31,+,1.81,1.18E-01
Notch signaling pathway (GO:0007219),9,3,1.65,+,1.81,2.31E-01
maturation of SSU-rRNA (GO:0030490),15,5,2.76,+,1.81,1.45E-01
maturation of 5.8S rRNA (GO:0000460),9,3,1.65,+,1.81,2.31E-01
negative regulation of chromosome organization (GO:2001251),9,3,1.65,+,1.81,2.31E-01
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),3,1,0.55,+,1.81,4.24E-01
regulation of Rho protein signal transduction (GO:0035023),3,1,0.55,+,1.81,4.24E-01
positive regulation of ion transport (GO:0043270),3,1,0.55,+,1.81,4.24E-01
cytokine-mediated signaling pathway (GO:0019221),3,1,0.55,+,1.81,4.24E-01
ceramide biosynthetic process (GO:0046513),6,2,1.1,+,1.81,3.02E-01
peptidyl-tyrosine phosphorylation (GO:0018108),3,1,0.55,+,1.81,4.24E-01
peroxisomal transport (GO:0043574),12,4,2.21,+,1.81,1.82E-01
cellular response to oxidative stress (GO:0034599),6,2,1.1,+,1.81,3.02E-01
chromosome localization (GO:0050000),3,1,0.55,+,1.81,4.24E-01
C-terminal protein amino acid modification (GO:0018410),3,1,0.55,+,1.81,4.24E-01
mitochondrial respiratory chain complex III assembly (GO:0034551),3,1,0.55,+,1.81,4.24E-01
histone ubiquitination (GO:0016574),6,2,1.1,+,1.81,3.02E-01
positive regulation of Wnt signaling pathway (GO:0030177),3,1,0.55,+,1.81,4.24E-01
regulation of glucose metabolic process (GO:0010906),3,1,0.55,+,1.81,4.24E-01
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),3,1,0.55,+,1.81,4.24E-01
regulation of translational initiation (GO:0006446),3,1,0.55,+,1.81,4.24E-01
innate immune response (GO:0045087),12,4,2.21,+,1.81,1.82E-01
mitochondrial respiratory chain complex I assembly (GO:0032981),3,1,0.55,+,1.81,4.24E-01
NADP metabolic process (GO:0006739),3,1,0.55,+,1.81,4.24E-01
regulation of reproductive process (GO:2000241),6,2,1.1,+,1.81,3.02E-01
glycogen biosynthetic process (GO:0005978),3,1,0.55,+,1.81,4.24E-01
regulation of DNA metabolic process (GO:0051052),12,4,2.21,+,1.81,1.82E-01
peptidyl-lysine trimethylation (GO:0018023),3,1,0.55,+,1.81,4.24E-01
histone exchange (GO:0043486),6,2,1.1,+,1.81,3.02E-01
regulation of protein localization to membrane (GO:1905475),3,1,0.55,+,1.81,4.24E-01
substrate adhesion-dependent cell spreading (GO:0034446),3,1,0.55,+,1.81,4.24E-01
establishment of chromosome localization (GO:0051303),3,1,0.55,+,1.81,4.24E-01
positive regulation of MAP kinase activity (GO:0043406),6,2,1.1,+,1.81,3.02E-01
regulation of hormone levels (GO:0010817),3,1,0.55,+,1.81,4.24E-01
positive regulation of ion transmembrane transport (GO:0034767),3,1,0.55,+,1.81,4.24E-01
positive regulation of transmembrane transport (GO:0034764),3,1,0.55,+,1.81,4.24E-01
mRNA splice site selection (GO:0006376),3,1,0.55,+,1.81,4.24E-01
transcription by RNA polymerase I (GO:0006360),6,2,1.1,+,1.81,3.02E-01
organic cation transport (GO:0015695),3,1,0.55,+,1.81,4.24E-01
positive regulation of canonical Wnt signaling pathway (GO:0090263),3,1,0.55,+,1.81,4.24E-01
embryonic morphogenesis (GO:0048598),6,2,1.1,+,1.81,3.02E-01
cellular response to chemical stress (GO:0062197),6,2,1.1,+,1.81,3.02E-01
cellular response to insulin stimulus (GO:0032869),3,1,0.55,+,1.81,4.24E-01
cytokinetic process (GO:0032506),3,1,0.55,+,1.81,4.24E-01
response to insulin (GO:0032868),3,1,0.55,+,1.81,4.24E-01
nuclear envelope organization (GO:0006998),3,1,0.55,+,1.81,4.24E-01
"mRNA cis splicing, via spliceosome (GO:0045292)",12,4,2.21,+,1.81,1.82E-01
positive regulation of cation channel activity (GO:2001259),3,1,0.55,+,1.81,4.24E-01
negative regulation of programmed cell death (GO:0043069),3,1,0.55,+,1.81,4.24E-01
negative regulation of apoptotic process (GO:0043066),3,1,0.55,+,1.81,4.24E-01
regulation of cysteine-type endopeptidase activity (GO:2000116),3,1,0.55,+,1.81,4.24E-01
centriole replication (GO:0007099),3,1,0.55,+,1.81,4.24E-01
glucan biosynthetic process (GO:0009250),3,1,0.55,+,1.81,4.24E-01
negative regulation of DNA replication (GO:0008156),3,1,0.55,+,1.81,4.24E-01
peptidyl-tyrosine modification (GO:0018212),3,1,0.55,+,1.81,4.24E-01
RNA-dependent DNA biosynthetic process (GO:0006278),3,1,0.55,+,1.81,4.24E-01
tumor necrosis factor-mediated signaling pathway (GO:0033209),3,1,0.55,+,1.81,4.24E-01
response to tumor necrosis factor (GO:0034612),3,1,0.55,+,1.81,4.24E-01
positive regulation of ion transmembrane transporter activity (GO:0032414),3,1,0.55,+,1.81,4.24E-01
positive regulation of transporter activity (GO:0032411),3,1,0.55,+,1.81,4.24E-01
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),3,1,0.55,+,1.81,4.24E-01
extrinsic apoptotic signaling pathway (GO:0097191),3,1,0.55,+,1.81,4.24E-01
heparan sulfate proteoglycan metabolic process (GO:0030201),3,1,0.55,+,1.81,4.24E-01
receptor internalization (GO:0031623),6,2,1.1,+,1.81,3.02E-01
cellular response to tumor necrosis factor (GO:0071356),3,1,0.55,+,1.81,4.24E-01
cellular response to cytokine stimulus (GO:0071345),3,1,0.55,+,1.81,4.24E-01
cortical actin cytoskeleton organization (GO:0030866),6,2,1.1,+,1.81,3.02E-01
"regulation of mRNA splicing, via spliceosome (GO:0048024)",28,9,5.15,+,1.75,7.75E-02
alcohol metabolic process (GO:0006066),28,9,5.15,+,1.75,7.75E-02
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",25,8,4.59,+,1.74,9.41E-02
"alternative mRNA splicing, via spliceosome (GO:0000380)",25,8,4.59,+,1.74,9.41E-02
ncRNA processing (GO:0034470),69,22,12.68,+,1.74,1.05E-02
ribose phosphate metabolic process (GO:0019693),69,22,12.68,+,1.74,1.05E-02
ribonucleotide metabolic process (GO:0009259),69,22,12.68,+,1.74,1.05E-02
cellular carbohydrate metabolic process (GO:0044262),22,7,4.04,+,1.73,1.15E-01
MAPK cascade (GO:0000165),22,7,4.04,+,1.73,1.15E-01
monocarboxylic acid metabolic process (GO:0032787),38,12,6.98,+,1.72,5.20E-02
response to external biotic stimulus (GO:0043207),16,5,2.94,+,1.7,1.75E-01
response to other organism (GO:0051707),16,5,2.94,+,1.7,1.75E-01
response to biotic stimulus (GO:0009607),16,5,2.94,+,1.7,1.75E-01
phospholipid metabolic process (GO:0006644),32,10,5.88,+,1.7,7.54E-02
ribosomal large subunit assembly (GO:0000027),16,5,2.94,+,1.7,1.75E-01
interspecies interaction between organisms (GO:0044419),16,5,2.94,+,1.7,1.75E-01
carbohydrate metabolic process (GO:0005975),48,15,8.82,+,1.7,3.53E-02
organophosphate metabolic process (GO:0019637),133,41,24.44,+,1.68,1.20E-03
protein localization to mitochondrion (GO:0070585),13,4,2.39,+,1.67,2.19E-01
"retrograde transport, endosome to Golgi (GO:0042147)",13,4,2.39,+,1.67,2.19E-01
embryo development (GO:0009790),13,4,2.39,+,1.67,2.19E-01
regulation of TOR signaling (GO:0032006),13,4,2.39,+,1.67,2.19E-01
establishment of protein localization to mitochondrion (GO:0072655),13,4,2.39,+,1.67,2.19E-01
cytosolic transport (GO:0016482),13,4,2.39,+,1.67,2.19E-01
positive regulation of MAPK cascade (GO:0043410),13,4,2.39,+,1.67,2.19E-01
protein targeting to mitochondrion (GO:0006626),13,4,2.39,+,1.67,2.19E-01
hexose metabolic process (GO:0019318),13,4,2.39,+,1.67,2.19E-01
regulation of ion transport (GO:0043269),23,7,4.23,+,1.66,1.35E-01
nucleotide metabolic process (GO:0009117),79,24,14.52,+,1.65,1.33E-02
nucleoside phosphate metabolic process (GO:0006753),79,24,14.52,+,1.65,1.33E-02
purine ribonucleotide metabolic process (GO:0009150),66,20,12.13,+,1.65,2.28E-02
regulation of mRNA processing (GO:0050684),33,10,6.06,+,1.65,8.78E-02
small molecule catabolic process (GO:0044282),43,13,7.9,+,1.65,5.85E-02
ribonucleoprotein complex biogenesis (GO:0022613),113,34,20.77,+,1.64,4.32E-03
vesicle-mediated transport to the plasma membrane (GO:0098876),10,3,1.84,+,1.63,2.79E-01
lipoprotein metabolic process (GO:0042157),20,6,3.68,+,1.63,1.66E-01
nucleobase metabolic process (GO:0009112),10,3,1.84,+,1.63,2.79E-01
purine nucleotide metabolic process (GO:0006163),70,21,12.86,+,1.63,2.20E-02
protein import into mitochondrial matrix (GO:0030150),10,3,1.84,+,1.63,2.79E-01
glycerophospholipid biosynthetic process (GO:0046474),10,3,1.84,+,1.63,2.79E-01
protein targeting (GO:0006605),60,18,11.03,+,1.63,3.21E-02
Golgi to plasma membrane transport (GO:0006893),10,3,1.84,+,1.63,2.79E-01
cortical cytoskeleton organization (GO:0030865),10,3,1.84,+,1.63,2.79E-01
respiratory electron transport chain (GO:0022904),27,8,4.96,+,1.61,1.29E-01
electron transport chain (GO:0022900),27,8,4.96,+,1.61,1.29E-01
dephosphorylation (GO:0016311),44,13,8.09,+,1.61,6.73E-02
intra-Golgi vesicle-mediated transport (GO:0006891),17,5,3.12,+,1.6,2.06E-01
ncRNA metabolic process (GO:0034660),82,24,15.07,+,1.59,1.97E-02
anion transport (GO:0006820),48,14,8.82,+,1.59,6.44E-02
lipid biosynthetic process (GO:0008610),38,11,6.98,+,1.58,9.67E-02
purine-containing compound metabolic process (GO:0072521),77,22,14.15,+,1.55,3.09E-02
positive regulation of translation (GO:0045727),7,2,1.29,+,1.55,3.68E-01
negative regulation of TOR signaling (GO:0032007),7,2,1.29,+,1.55,3.68E-01
regulation of response to DNA damage stimulus (GO:2001020),7,2,1.29,+,1.55,3.68E-01
aromatic amino acid family catabolic process (GO:0009074),7,2,1.29,+,1.55,3.68E-01
aromatic amino acid family metabolic process (GO:0009072),7,2,1.29,+,1.55,3.68E-01
negative regulation of mitotic sister chromatid segregation (GO:0033048),7,2,1.29,+,1.55,3.68E-01
negative regulation of sister chromatid segregation (GO:0033046),7,2,1.29,+,1.55,3.68E-01
RNA methylation (GO:0001510),7,2,1.29,+,1.55,3.68E-01
protein localization to cell periphery (GO:1990778),14,4,2.57,+,1.55,2.58E-01
meiotic chromosome separation (GO:0051307),7,2,1.29,+,1.55,3.68E-01
spindle localization (GO:0051653),7,2,1.29,+,1.55,3.68E-01
negative regulation of mitotic sister chromatid separation (GO:2000816),7,2,1.29,+,1.55,3.68E-01
inorganic anion transport (GO:0015698),7,2,1.29,+,1.55,3.68E-01
central nervous system development (GO:0007417),14,4,2.57,+,1.55,2.58E-01
ribosomal subunit export from nucleus (GO:0000054),7,2,1.29,+,1.55,3.68E-01
establishment of spindle localization (GO:0051293),7,2,1.29,+,1.55,3.68E-01
mitotic spindle assembly checkpoint (GO:0007094),7,2,1.29,+,1.55,3.68E-01
negative regulation of mitotic metaphase/anaphase transition (GO:0045841),7,2,1.29,+,1.55,3.68E-01
negative regulation of mitotic nuclear division (GO:0045839),7,2,1.29,+,1.55,3.68E-01
COPII-coated vesicle budding (GO:0090114),7,2,1.29,+,1.55,3.68E-01
regulation of anatomical structure morphogenesis (GO:0022603),14,4,2.57,+,1.55,2.58E-01
nucleobase-containing small molecule metabolic process (GO:0055086),92,26,16.91,+,1.54,2.29E-02
regulation of RNA splicing (GO:0043484),32,9,5.88,+,1.53,1.40E-01
organic hydroxy compound metabolic process (GO:1901615),32,9,5.88,+,1.53,1.40E-01
signal transduction by protein phosphorylation (GO:0023014),25,7,4.59,+,1.52,1.81E-01
protein dephosphorylation (GO:0006470),25,7,4.59,+,1.52,1.81E-01
carboxylic acid catabolic process (GO:0046395),25,7,4.59,+,1.52,1.81E-01
organic acid catabolic process (GO:0016054),25,7,4.59,+,1.52,1.81E-01
regulation of mRNA metabolic process (GO:1903311),36,10,6.62,+,1.51,1.32E-01
cellular respiration (GO:0045333),36,10,6.62,+,1.51,1.32E-01
response to radiation (GO:0009314),18,5,3.31,+,1.51,2.39E-01
"DNA-templated transcription, elongation (GO:0006354)",18,5,3.31,+,1.51,2.39E-01
defense response (GO:0006952),18,5,3.31,+,1.51,2.39E-01
peroxisome organization (GO:0007031),18,5,3.31,+,1.51,2.39E-01
energy derivation by oxidation of organic compounds (GO:0015980),40,11,7.35,+,1.5,1.25E-01
cellular modified amino acid metabolic process (GO:0006575),40,11,7.35,+,1.5,1.25E-01
positive regulation of signal transduction (GO:0009967),33,9,6.06,+,1.48,1.59E-01
RNA modification (GO:0009451),22,6,4.04,+,1.48,2.21E-01
regulation of metal ion transport (GO:0010959),11,3,2.02,+,1.48,3.29E-01
regulation of protein serine/threonine kinase activity (GO:0071900),22,6,4.04,+,1.48,2.21E-01
cellular response to abiotic stimulus (GO:0071214),11,3,2.02,+,1.48,3.29E-01
"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",11,3,2.02,+,1.48,3.29E-01
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),11,3,2.02,+,1.48,3.29E-01
cellular response to environmental stimulus (GO:0104004),11,3,2.02,+,1.48,3.29E-01
regulation of apoptotic process (GO:0042981),11,3,2.02,+,1.48,3.29E-01
protein targeting to vacuole (GO:0006623),11,3,2.02,+,1.48,3.29E-01
regulation of programmed cell death (GO:0043067),11,3,2.02,+,1.48,3.29E-01
cellular response to organonitrogen compound (GO:0071417),11,3,2.02,+,1.48,3.29E-01
cell cycle checkpoint (GO:0000075),26,7,4.78,+,1.47,2.06E-01
cellular amino acid biosynthetic process (GO:0008652),15,4,2.76,+,1.45,2.98E-01
immune system process (GO:0002376),15,4,2.76,+,1.45,2.98E-01
immune response (GO:0006955),15,4,2.76,+,1.45,2.98E-01
defense response to other organism (GO:0098542),15,4,2.76,+,1.45,2.98E-01
alpha-amino acid metabolic process (GO:1901605),34,9,6.25,+,1.44,1.79E-01
organophosphate biosynthetic process (GO:0090407),87,23,15.99,+,1.44,5.65E-02
ribonucleoside triphosphate metabolic process (GO:0009199),38,10,6.98,+,1.43,1.67E-01
nucleoside triphosphate biosynthetic process (GO:0009142),38,10,6.98,+,1.43,1.67E-01
mitochondrial ATP synthesis coupled electron transport (GO:0042775),19,5,3.49,+,1.43,2.73E-01
membrane lipid biosynthetic process (GO:0046467),19,5,3.49,+,1.43,2.73E-01
ribonucleoside triphosphate biosynthetic process (GO:0009201),38,10,6.98,+,1.43,1.67E-01
protein transmembrane import into intracellular organelle (GO:0044743),19,5,3.49,+,1.43,2.73E-01
peptide metabolic process (GO:0006518),141,37,25.91,+,1.43,2.20E-02
oxidative phosphorylation (GO:0006119),27,7,4.96,+,1.41,2.32E-01
glycerolipid metabolic process (GO:0046486),31,8,5.7,+,1.4,2.15E-01
cellular amide metabolic process (GO:0043603),159,41,29.22,+,1.4,2.13E-02
positive regulation of cell communication (GO:0010647),35,9,6.43,+,1.4,2.00E-01
positive regulation of signaling (GO:0023056),35,9,6.43,+,1.4,2.00E-01
positive regulation of response to stimulus (GO:0048584),35,9,6.43,+,1.4,2.00E-01
ATP synthesis coupled proton transport (GO:0015986),35,9,6.43,+,1.4,2.00E-01
"energy coupled proton transport, down electrochemical gradient (GO:0015985)",35,9,6.43,+,1.4,2.00E-01
carbohydrate derivative metabolic process (GO:1901135),141,36,25.91,+,1.39,3.32E-02
polysaccharide biosynthetic process (GO:0000271),4,1,0.74,+,1.36,5.21E-01
apoptotic cell clearance (GO:0043277),4,1,0.74,+,1.36,5.21E-01
glucose 6-phosphate metabolic process (GO:0051156),4,1,0.74,+,1.36,5.21E-01
proteasome assembly (GO:0043248),4,1,0.74,+,1.36,5.21E-01
nucleoside triphosphate metabolic process (GO:0009141),40,10,7.35,+,1.36,2.06E-01
phospholipid dephosphorylation (GO:0046839),8,2,1.47,+,1.36,4.32E-01
RNA interference (GO:0016246),4,1,0.74,+,1.36,5.21E-01
telomere capping (GO:0016233),4,1,0.74,+,1.36,5.21E-01
negative regulation of cell cycle process (GO:0010948),20,5,3.68,+,1.36,3.08E-01
positive regulation of TOR signaling (GO:0032008),4,1,0.74,+,1.36,5.21E-01
ATP synthesis coupled electron transport (GO:0042773),20,5,3.68,+,1.36,3.08E-01
integrin-mediated signaling pathway (GO:0007229),4,1,0.74,+,1.36,5.21E-01
energy reserve metabolic process (GO:0006112),4,1,0.74,+,1.36,5.21E-01
negative regulation of protein kinase activity (GO:0006469),4,1,0.74,+,1.36,5.21E-01
cell-substrate adhesion (GO:0031589),8,2,1.47,+,1.36,4.32E-01
negative regulation of chromosome separation (GO:1905819),8,2,1.47,+,1.36,4.32E-01
intra-S DNA damage checkpoint (GO:0031573),4,1,0.74,+,1.36,5.21E-01
negative regulation of intracellular signal transduction (GO:1902532),16,4,2.94,+,1.36,3.39E-01
tRNA modification (GO:0006400),4,1,0.74,+,1.36,5.21E-01
ATP biosynthetic process (GO:0006754),36,9,6.62,+,1.36,2.22E-01
monosaccharide metabolic process (GO:0005996),16,4,2.94,+,1.36,3.39E-01
cellular carbohydrate catabolic process (GO:0044275),4,1,0.74,+,1.36,5.21E-01
glycogen metabolic process (GO:0005977),4,1,0.74,+,1.36,5.21E-01
retina development in camera-type eye (GO:0060041),4,1,0.74,+,1.36,5.21E-01
cellular response to amino acid starvation (GO:0034198),4,1,0.74,+,1.36,5.21E-01
aspartate family amino acid biosynthetic process (GO:0009067),4,1,0.74,+,1.36,5.21E-01
negative regulation of phosphorus metabolic process (GO:0010563),8,2,1.47,+,1.36,4.32E-01
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),4,1,0.74,+,1.36,5.21E-01
negative regulation of transferase activity (GO:0051348),4,1,0.74,+,1.36,5.21E-01
cellular glucan metabolic process (GO:0006073),4,1,0.74,+,1.36,5.21E-01
regulation of Notch signaling pathway (GO:0008593),4,1,0.74,+,1.36,5.21E-01
cell migration (GO:0016477),16,4,2.94,+,1.36,3.39E-01
reciprocal meiotic recombination (GO:0007131),8,2,1.47,+,1.36,4.32E-01
UDP-N-acetylglucosamine metabolic process (GO:0006047),4,1,0.74,+,1.36,5.21E-01
rRNA methylation (GO:0031167),4,1,0.74,+,1.36,5.21E-01
negative regulation of phosphate metabolic process (GO:0045936),8,2,1.47,+,1.36,4.32E-01
cellular polysaccharide biosynthetic process (GO:0033692),4,1,0.74,+,1.36,5.21E-01
negative regulation of kinase activity (GO:0033673),4,1,0.74,+,1.36,5.21E-01
negative regulation of chromosome segregation (GO:0051985),8,2,1.47,+,1.36,4.32E-01
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100),8,2,1.47,+,1.36,4.32E-01
homologous recombination (GO:0035825),8,2,1.47,+,1.36,4.32E-01
response to bacterium (GO:0009617),4,1,0.74,+,1.36,5.21E-01
"regulation of synaptic transmission, glutamatergic (GO:0051966)",4,1,0.74,+,1.36,5.21E-01
iron ion homeostasis (GO:0055072),4,1,0.74,+,1.36,5.21E-01
ceramide metabolic process (GO:0006672),8,2,1.47,+,1.36,4.32E-01
regulation of stress-activated MAPK cascade (GO:0032872),8,2,1.47,+,1.36,4.32E-01
regulation of cellular response to stress (GO:0080135),16,4,2.94,+,1.36,3.39E-01
regulation of response to stress (GO:0080134),16,4,2.94,+,1.36,3.39E-01
membrane lipid metabolic process (GO:0006643),20,5,3.68,+,1.36,3.08E-01
cellular process involved in reproduction in multicellular organism (GO:0022412),8,2,1.47,+,1.36,4.32E-01
response to unfolded protein (GO:0006986),20,5,3.68,+,1.36,3.08E-01
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),4,1,0.74,+,1.36,5.21E-01
establishment of spindle orientation (GO:0051294),4,1,0.74,+,1.36,5.21E-01
camera-type eye development (GO:0043010),4,1,0.74,+,1.36,5.21E-01
regulation of stress-activated protein kinase signaling cascade (GO:0070302),8,2,1.47,+,1.36,4.32E-01
spindle assembly (GO:0051225),8,2,1.47,+,1.36,4.32E-01
mitotic spindle organization (GO:0007052),8,2,1.47,+,1.36,4.32E-01
post-translational protein modification (GO:0043687),4,1,0.74,+,1.36,5.21E-01
Golgi organization (GO:0007030),20,5,3.68,+,1.36,3.08E-01
plasma membrane organization (GO:0007009),4,1,0.74,+,1.36,5.21E-01
inner mitochondrial membrane organization (GO:0007007),4,1,0.74,+,1.36,5.21E-01
Golgi vesicle budding (GO:0048194),8,2,1.47,+,1.36,4.32E-01
cellular response to unfolded protein (GO:0034620),20,5,3.68,+,1.36,3.08E-01
response to endoplasmic reticulum stress (GO:0034976),20,5,3.68,+,1.36,3.08E-01
histone H2A ubiquitination (GO:0033522),4,1,0.74,+,1.36,5.21E-01
cellular iron ion homeostasis (GO:0006879),4,1,0.74,+,1.36,5.21E-01
glucan metabolic process (GO:0044042),4,1,0.74,+,1.36,5.21E-01
multivesicular body sorting pathway (GO:0071985),12,3,2.21,+,1.36,3.79E-01
transcription preinitiation complex assembly (GO:0070897),12,3,2.21,+,1.36,3.79E-01
phosphatidylinositol phosphorylation (GO:0046854),12,3,2.21,+,1.36,3.79E-01
RNA polymerase II preinitiation complex assembly (GO:0051123),12,3,2.21,+,1.36,3.79E-01
protein localization to plasma membrane (GO:0072659),12,3,2.21,+,1.36,3.79E-01
organophosphate catabolic process (GO:0046434),12,3,2.21,+,1.36,3.79E-01
late endosome to vacuole transport (GO:0045324),12,3,2.21,+,1.36,3.79E-01
cytoskeleton-dependent cytokinesis (GO:0061640),12,3,2.21,+,1.36,3.79E-01
regulation of cell morphogenesis (GO:0022604),12,3,2.21,+,1.36,3.79E-01
organic acid metabolic process (GO:0006082),93,23,17.09,+,1.35,9.75E-02
purine nucleoside triphosphate biosynthetic process (GO:0009145),37,9,6.8,+,1.32,2.45E-01
purine ribonucleoside triphosphate biosynthetic process (GO:0009206),37,9,6.8,+,1.32,2.45E-01
purine ribonucleoside triphosphate metabolic process (GO:0009205),37,9,6.8,+,1.32,2.45E-01
phosphate-containing compound metabolic process (GO:0006796),309,75,56.78,+,1.32,9.95E-03
carboxylic acid metabolic process (GO:0019752),91,22,16.72,+,1.32,1.22E-01
peptidyl-serine phosphorylation (GO:0018105),29,7,5.33,+,1.31,2.87E-01
transcription initiation from RNA polymerase II promoter (GO:0006367),29,7,5.33,+,1.31,2.87E-01
peptidyl-serine modification (GO:0018209),29,7,5.33,+,1.31,2.87E-01
vacuolar transport (GO:0007034),29,7,5.33,+,1.31,2.87E-01
organelle fusion (GO:0048284),54,13,9.92,+,1.31,2.00E-01
response to external stimulus (GO:0009605),79,19,14.52,+,1.31,1.47E-01
protein maturation (GO:0051604),25,6,4.59,+,1.31,3.13E-01
phosphorus metabolic process (GO:0006793),313,75,57.52,+,1.3,1.31E-02
oxoacid metabolic process (GO:0043436),92,22,16.91,+,1.3,1.32E-01
regulation of cell cycle (GO:0051726),67,16,12.31,+,1.3,1.78E-01
protein processing (GO:0016485),21,5,3.86,+,1.3,3.44E-01
fatty acid metabolic process (GO:0006631),21,5,3.86,+,1.3,3.44E-01
small molecule metabolic process (GO:0044281),206,49,37.86,+,1.29,4.33E-02
purine nucleoside triphosphate metabolic process (GO:0009144),38,9,6.98,+,1.29,2.68E-01
nitrogen compound transport (GO:0071705),241,57,44.29,+,1.29,3.43E-02
membrane fusion (GO:0061025),55,13,10.11,+,1.29,2.18E-01
negative regulation of cell cycle (GO:0045786),34,8,6.25,+,1.28,2.91E-01
protein folding (GO:0006457),34,8,6.25,+,1.28,2.91E-01
cellular response to starvation (GO:0009267),17,4,3.12,+,1.28,3.81E-01
cellular response to nutrient levels (GO:0031669),17,4,3.12,+,1.28,3.81E-01
cellular response to extracellular stimulus (GO:0031668),17,4,3.12,+,1.28,3.81E-01
negative regulation of cell communication (GO:0010648),30,7,5.51,+,1.27,3.16E-01
negative regulation of signaling (GO:0023057),30,7,5.51,+,1.27,3.16E-01
negative regulation of signal transduction (GO:0009968),30,7,5.51,+,1.27,3.16E-01
cell-cell adhesion (GO:0098609),43,10,7.9,+,1.27,2.71E-01
organic substance transport (GO:0071702),263,61,48.33,+,1.26,4.03E-02
protein targeting to ER (GO:0045047),13,3,2.39,+,1.26,4.28E-01
cytoplasmic microtubule organization (GO:0031122),13,3,2.39,+,1.26,4.28E-01
cellular response to nitrogen compound (GO:1901699),13,3,2.39,+,1.26,4.28E-01
establishment of protein localization to endoplasmic reticulum (GO:0072599),13,3,2.39,+,1.26,4.28E-01
ATP-dependent chromatin remodeling (GO:0043044),13,3,2.39,+,1.26,4.28E-01
vesicle fusion (GO:0006906),52,12,9.56,+,1.26,2.53E-01
mitochondrion organization (GO:0007005),52,12,9.56,+,1.26,2.53E-01
organelle membrane fusion (GO:0090174),52,12,9.56,+,1.26,2.53E-01
proton transmembrane transport (GO:1902600),39,9,7.17,+,1.26,2.93E-01
regulation of response to stimulus (GO:0048583),127,29,23.34,+,1.24,1.41E-01
organelle assembly (GO:0070925),92,21,16.91,+,1.24,1.86E-01
phosphatidylinositol metabolic process (GO:0046488),22,5,4.04,+,1.24,3.80E-01
protein transmembrane transport (GO:0071806),22,5,4.04,+,1.24,3.80E-01
intracellular protein transmembrane transport (GO:0065002),22,5,4.04,+,1.24,3.80E-01
translational elongation (GO:0006414),97,22,17.83,+,1.23,1.87E-01
translation (GO:0006412),97,22,17.83,+,1.23,1.87E-01
negative regulation of response to stimulus (GO:0048585),31,7,5.7,+,1.23,3.45E-01
amide biosynthetic process (GO:0043604),107,24,19.66,+,1.22,1.89E-01
ribose phosphate biosynthetic process (GO:0046390),58,13,10.66,+,1.22,2.74E-01
ribonucleotide biosynthetic process (GO:0009260),58,13,10.66,+,1.22,2.74E-01
cellular component biogenesis (GO:0044085),313,70,57.52,+,1.22,5.55E-02
regulation of signal transduction (GO:0009966),121,27,22.24,+,1.21,1.79E-01
tissue morphogenesis (GO:0048729),9,2,1.65,+,1.21,4.92E-01
TOR signaling (GO:0031929),18,4,3.31,+,1.21,4.21E-01
M phase (GO:0000279),9,2,1.65,+,1.21,4.92E-01
peptidyl-threonine phosphorylation (GO:0018107),9,2,1.65,+,1.21,4.92E-01
cell recognition (GO:0008037),9,2,1.65,+,1.21,4.92E-01
regulation of intracellular pH (GO:0051453),9,2,1.65,+,1.21,4.92E-01
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),9,2,1.65,+,1.21,4.92E-01
gamete generation (GO:0007276),9,2,1.65,+,1.21,4.92E-01
stress-activated MAPK cascade (GO:0051403),9,2,1.65,+,1.21,4.92E-01
protein import into peroxisome matrix (GO:0016558),9,2,1.65,+,1.21,4.92E-01
multi-organism process (GO:0051704),9,2,1.65,+,1.21,4.92E-01
DNA integrity checkpoint (GO:0031570),18,4,3.31,+,1.21,4.21E-01
regulation of Wnt signaling pathway (GO:0030111),9,2,1.65,+,1.21,4.92E-01
alcohol biosynthetic process (GO:0046165),18,4,3.31,+,1.21,4.21E-01
organophosphate ester transport (GO:0015748),9,2,1.65,+,1.21,4.92E-01
multicellular organismal reproductive process (GO:0048609),9,2,1.65,+,1.21,4.92E-01
meiosis I cell cycle phase (GO:0098764),9,2,1.65,+,1.21,4.92E-01
meiotic cell cycle phase (GO:0098762),9,2,1.65,+,1.21,4.92E-01
telophase (GO:0051326),9,2,1.65,+,1.21,4.92E-01
macromolecule methylation (GO:0043414),18,4,3.31,+,1.21,4.21E-01
methylation (GO:0032259),18,4,3.31,+,1.21,4.21E-01
meiotic telophase I (GO:0007134),9,2,1.65,+,1.21,4.92E-01
biological phase (GO:0044848),9,2,1.65,+,1.21,4.92E-01
meiosis I (GO:0007127),9,2,1.65,+,1.21,4.92E-01
regulation of ion transmembrane transport (GO:0034765),9,2,1.65,+,1.21,4.92E-01
regulation of transmembrane transport (GO:0034762),9,2,1.65,+,1.21,4.92E-01
response to extracellular stimulus (GO:0009991),18,4,3.31,+,1.21,4.21E-01
negative regulation of cell cycle G2/M phase transition (GO:1902750),9,2,1.65,+,1.21,4.92E-01
negative regulation of mitotic cell cycle phase transition (GO:1901991),18,4,3.31,+,1.21,4.21E-01
cell cycle phase (GO:0022403),9,2,1.65,+,1.21,4.92E-01
regulation of cellular pH (GO:0030641),9,2,1.65,+,1.21,4.92E-01
DNA replication checkpoint (GO:0000076),9,2,1.65,+,1.21,4.92E-01
peptide biosynthetic process (GO:0043043),99,22,18.19,+,1.21,2.13E-01
response to starvation (GO:0042594),18,4,3.31,+,1.21,4.21E-01
sexual reproduction (GO:0019953),9,2,1.65,+,1.21,4.92E-01
multi-organism reproductive process (GO:0044703),9,2,1.65,+,1.21,4.92E-01
histone H4 acetylation (GO:0043967),9,2,1.65,+,1.21,4.92E-01
"positive regulation of DNA-templated transcription, elongation (GO:0032786)",9,2,1.65,+,1.21,4.92E-01
response to nutrient levels (GO:0031667),18,4,3.31,+,1.21,4.21E-01
regulation of pH (GO:0006885),9,2,1.65,+,1.21,4.92E-01
regulation of Ras protein signal transduction (GO:0046578),9,2,1.65,+,1.21,4.92E-01
phosphorylation (GO:0016310),194,43,35.65,+,1.21,1.23E-01
protein localization (GO:0008104),259,57,47.6,+,1.2,9.60E-02
nucleobase-containing compound transport (GO:0015931),41,9,7.53,+,1.19,3.43E-01
cellular amino acid metabolic process (GO:0006520),41,9,7.53,+,1.19,3.43E-01
nucleotide biosynthetic process (GO:0009165),64,14,11.76,+,1.19,2.93E-01
nucleoside phosphate biosynthetic process (GO:1901293),64,14,11.76,+,1.19,2.93E-01
organonitrogen compound biosynthetic process (GO:1901566),261,57,47.96,+,1.19,1.06E-01
cellular protein localization (GO:0034613),234,51,43,+,1.19,1.23E-01
protein import (GO:0017038),46,10,8.45,+,1.18,3.41E-01
negative regulation of cellular component organization (GO:0051129),23,5,4.23,+,1.18,4.15E-01
negative regulation of organelle organization (GO:0010639),23,5,4.23,+,1.18,4.15E-01
cellular response to topologically incorrect protein (GO:0035967),23,5,4.23,+,1.18,4.15E-01
response to topologically incorrect protein (GO:0035966),23,5,4.23,+,1.18,4.15E-01
negative regulation of mitotic cell cycle (GO:0045930),23,5,4.23,+,1.18,4.15E-01
reproduction (GO:0000003),46,10,8.45,+,1.18,3.41E-01
protein transport (GO:0015031),212,46,38.96,+,1.18,1.43E-01
peptide transport (GO:0015833),212,46,38.96,+,1.18,1.43E-01
establishment of protein localization (GO:0045184),217,47,39.88,+,1.18,1.43E-01
cellular lipid metabolic process (GO:0044255),74,16,13.6,+,1.18,2.91E-01
"DNA-templated transcription, initiation (GO:0006352)",37,8,6.8,+,1.18,3.71E-01
cellular macromolecule localization (GO:0070727),236,51,43.37,+,1.18,1.35E-01
amide transport (GO:0042886),213,46,39.14,+,1.18,1.51E-01
cell adhesion (GO:0007155),65,14,11.95,+,1.17,3.12E-01
biological adhesion (GO:0022610),65,14,11.95,+,1.17,3.12E-01
ion transport (GO:0006811),223,48,40.98,+,1.17,1.50E-01
vesicle organization (GO:0016050),107,23,19.66,+,1.17,2.52E-01
Ras protein signal transduction (GO:0007265),14,3,2.57,+,1.17,4.75E-01
regulation of cell death (GO:0010941),14,3,2.57,+,1.17,4.75E-01
response to hormone (GO:0009725),14,3,2.57,+,1.17,4.75E-01
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),14,3,2.57,+,1.17,4.75E-01
transcription elongation from RNA polymerase II promoter (GO:0006368),14,3,2.57,+,1.17,4.75E-01
chromatin remodeling (GO:0006338),28,6,5.15,+,1.17,4.10E-01
carbohydrate biosynthetic process (GO:0016051),14,3,2.57,+,1.17,4.75E-01
spindle organization (GO:0007051),14,3,2.57,+,1.17,4.75E-01
"regulation of DNA-templated transcription, elongation (GO:0032784)",14,3,2.57,+,1.17,4.75E-01
regulation of intracellular signal transduction (GO:1902531),80,17,14.7,+,1.16,3.07E-01
establishment of protein localization to organelle (GO:0072594),80,17,14.7,+,1.16,3.07E-01
protein polyubiquitination (GO:0000209),33,7,6.06,+,1.15,4.04E-01
glycoprotein metabolic process (GO:0009100),33,7,6.06,+,1.15,4.04E-01
endosomal transport (GO:0016197),33,7,6.06,+,1.15,4.04E-01
membrane organization (GO:0061024),137,29,25.18,+,1.15,2.46E-01
macromolecule localization (GO:0033036),280,59,51.46,+,1.15,1.57E-01
cellular response to external stimulus (GO:0071496),19,4,3.49,+,1.15,4.62E-01
negative regulation of cell cycle phase transition (GO:1901988),19,4,3.49,+,1.15,4.62E-01
mitotic cell cycle checkpoint (GO:0007093),19,4,3.49,+,1.15,4.62E-01
intracellular protein transport (GO:0006886),190,40,34.92,+,1.15,2.12E-01
membrane invagination (GO:0010324),43,9,7.9,+,1.14,3.94E-01
RNA processing (GO:0006396),182,38,33.45,+,1.14,2.34E-01
organonitrogen compound metabolic process (GO:1901564),806,168,148.12,+,1.13,4.52E-02
glycerophospholipid metabolic process (GO:0006650),24,5,4.41,+,1.13,4.51E-01
autophagosome assembly (GO:0000045),24,5,4.41,+,1.13,4.51E-01
autophagosome organization (GO:1905037),24,5,4.41,+,1.13,4.51E-01
protein modification by small protein removal (GO:0070646),24,5,4.41,+,1.13,4.51E-01
carbohydrate derivative biosynthetic process (GO:1901137),101,21,18.56,+,1.13,3.14E-01
peptidyl-amino acid modification (GO:0018193),101,21,18.56,+,1.13,3.14E-01
actin cytoskeleton organization (GO:0030036),77,16,14.15,+,1.13,3.45E-01
actin filament-based process (GO:0030029),77,16,14.15,+,1.13,3.45E-01
vesicle budding from membrane (GO:0006900),53,11,9.74,+,1.13,3.84E-01
regulation of protein modification process (GO:0031399),63,13,11.58,+,1.12,3.76E-01
positive regulation of nucleobase-containing compound metabolic process (GO:0045935),102,21,18.74,+,1.12,3.30E-01
positive regulation of biosynthetic process (GO:0009891),102,21,18.74,+,1.12,3.30E-01
nuclear-transcribed mRNA catabolic process (GO:0000956),34,7,6.25,+,1.12,4.34E-01
positive regulation of cellular biosynthetic process (GO:0031328),102,21,18.74,+,1.12,3.30E-01
localization (GO:0051179),667,137,122.57,+,1.12,9.25E-02
RNA transport (GO:0050658),39,8,7.17,+,1.12,4.26E-01
nucleic acid transport (GO:0050657),39,8,7.17,+,1.12,4.26E-01
autophagy (GO:0006914),39,8,7.17,+,1.12,4.26E-01
establishment of RNA localization (GO:0051236),39,8,7.17,+,1.12,4.26E-01
process utilizing autophagic mechanism (GO:0061919),39,8,7.17,+,1.12,4.26E-01
G protein-coupled receptor signaling pathway (GO:0007186),74,15,13.6,+,1.1,3.87E-01
signal transduction (GO:0007165),375,76,68.91,+,1.1,2.04E-01
transport (GO:0006810),602,122,110.63,+,1.1,1.38E-01
establishment of localization (GO:0051234),612,124,112.47,+,1.1,1.37E-01
transmembrane transport (GO:0055085),203,41,37.31,+,1.1,2.91E-01
mitotic cytokinesis (GO:0000281),10,2,1.84,+,1.09,5.48E-01
purine ribonucleotide biosynthetic process (GO:0009152),55,11,10.11,+,1.09,4.30E-01
heme metabolic process (GO:0042168),5,1,0.92,+,1.09,6.01E-01
eye development (GO:0001654),5,1,0.92,+,1.09,6.01E-01
Rho protein signal transduction (GO:0007266),5,1,0.92,+,1.09,6.01E-01
regulation of chromatin organization (GO:1902275),10,2,1.84,+,1.09,5.48E-01
regulation of nuclear division (GO:0051783),15,3,2.76,+,1.09,5.20E-01
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),5,1,0.92,+,1.09,6.01E-01
non-motile cilium assembly (GO:1905515),5,1,0.92,+,1.09,6.01E-01
protein O-linked glycosylation (GO:0006493),5,1,0.92,+,1.09,6.01E-01
glutamate receptor signaling pathway (GO:0007215),5,1,0.92,+,1.09,6.01E-01
sphingolipid biosynthetic process (GO:0030148),15,3,2.76,+,1.09,5.20E-01
heme biosynthetic process (GO:0006783),5,1,0.92,+,1.09,6.01E-01
porphyrin-containing compound metabolic process (GO:0006778),5,1,0.92,+,1.09,6.01E-01
activation of MAPK activity (GO:0000187),5,1,0.92,+,1.09,6.01E-01
polysaccharide metabolic process (GO:0005976),5,1,0.92,+,1.09,6.01E-01
cellular polysaccharide metabolic process (GO:0044264),5,1,0.92,+,1.09,6.01E-01
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),5,1,0.92,+,1.09,6.01E-01
peptidyl-lysine methylation (GO:0018022),10,2,1.84,+,1.09,5.48E-01
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),15,3,2.76,+,1.09,5.20E-01
regulation of membrane potential (GO:0042391),30,6,5.51,+,1.09,4.74E-01
tricarboxylic acid cycle (GO:0006099),5,1,0.92,+,1.09,6.01E-01
tetrapyrrole metabolic process (GO:0033013),5,1,0.92,+,1.09,6.01E-01
potassium ion transmembrane transport (GO:0071805),20,4,3.68,+,1.09,5.01E-01
localization of cell (GO:0051674),20,4,3.68,+,1.09,5.01E-01
regulation of mitotic metaphase/anaphase transition (GO:0030071),10,2,1.84,+,1.09,5.48E-01
mitotic DNA replication checkpoint (GO:0033314),5,1,0.92,+,1.09,6.01E-01
posttranscriptional gene silencing (GO:0016441),10,2,1.84,+,1.09,5.48E-01
lipid homeostasis (GO:0055088),5,1,0.92,+,1.09,6.01E-01
resolution of meiotic recombination intermediates (GO:0000712),5,1,0.92,+,1.09,6.01E-01
autophagy of nucleus (GO:0044804),10,2,1.84,+,1.09,5.48E-01
establishment of cell polarity (GO:0030010),5,1,0.92,+,1.09,6.01E-01
sensory organ development (GO:0007423),5,1,0.92,+,1.09,6.01E-01
regulation of cation channel activity (GO:2001257),5,1,0.92,+,1.09,6.01E-01
visual system development (GO:0150063),5,1,0.92,+,1.09,6.01E-01
sensory system development (GO:0048880),5,1,0.92,+,1.09,6.01E-01
production of miRNAs involved in gene silencing by miRNA (GO:0035196),5,1,0.92,+,1.09,6.01E-01
post-transcriptional gene silencing by RNA (GO:0035194),10,2,1.84,+,1.09,5.48E-01
cell motility (GO:0048870),20,4,3.68,+,1.09,5.01E-01
positive regulation of JNK cascade (GO:0046330),5,1,0.92,+,1.09,6.01E-01
response to cytokine (GO:0034097),5,1,0.92,+,1.09,6.01E-01
centrosome duplication (GO:0051298),5,1,0.92,+,1.09,6.01E-01
phagocytosis (GO:0006909),5,1,0.92,+,1.09,6.01E-01
protein K11-linked ubiquitination (GO:0070979),5,1,0.92,+,1.09,6.01E-01
protein catabolic process in the vacuole (GO:0007039),5,1,0.92,+,1.09,6.01E-01
vacuole organization (GO:0007033),30,6,5.51,+,1.09,4.74E-01
gene silencing by RNA (GO:0031047),10,2,1.84,+,1.09,5.48E-01
regulation of DNA replication (GO:0006275),5,1,0.92,+,1.09,6.01E-01
cytokinesis (GO:0000910),15,3,2.76,+,1.09,5.20E-01
cytoplasmic translation (GO:0002181),20,4,3.68,+,1.09,5.01E-01
chloride transport (GO:0006821),5,1,0.92,+,1.09,6.01E-01
potassium ion transport (GO:0006813),20,4,3.68,+,1.09,5.01E-01
intracellular transport (GO:0046907),267,53,49.07,+,1.08,3.02E-01
protein localization to organelle (GO:0033365),111,22,20.4,+,1.08,3.90E-01
monovalent inorganic cation transport (GO:0015672),111,22,20.4,+,1.08,3.90E-01
protein modification by small protein conjugation or removal (GO:0070647),106,21,19.48,+,1.08,3.94E-01
regulation of cell communication (GO:0010646),147,29,27.01,+,1.07,3.75E-01
regulation of signaling (GO:0023051),147,29,27.01,+,1.07,3.75E-01
protein ubiquitination (GO:0016567),71,14,13.05,+,1.07,4.32E-01
small molecule biosynthetic process (GO:0044283),66,13,12.13,+,1.07,4.39E-01
protein metabolic process (GO:0019538),615,121,113.02,+,1.07,2.27E-01
cation transport (GO:0006812),163,32,29.95,+,1.07,3.77E-01
regulation of protein phosphorylation (GO:0001932),51,10,9.37,+,1.07,4.62E-01
RNA catabolic process (GO:0006401),46,9,8.45,+,1.06,4.71E-01
macromolecule modification (GO:0043412),384,75,70.57,+,1.06,3.09E-01
protein phosphorylation (GO:0006468),123,24,22.6,+,1.06,4.12E-01
RNA localization (GO:0006403),41,8,7.53,+,1.06,4.81E-01
regulation of organelle organization (GO:0033043),82,16,15.07,+,1.06,4.39E-01
protein modification by small protein conjugation (GO:0032446),82,16,15.07,+,1.06,4.39E-01
ion transmembrane transport (GO:0034220),165,32,30.32,+,1.06,4.03E-01
programmed cell death (GO:0012501),31,6,5.7,+,1.05,5.05E-01
carboxylic acid biosynthetic process (GO:0046394),31,6,5.7,+,1.05,5.05E-01
purine-containing compound biosynthetic process (GO:0072522),62,12,11.39,+,1.05,4.68E-01
apoptotic process (GO:0006915),31,6,5.7,+,1.05,5.05E-01
organic acid biosynthetic process (GO:0016053),31,6,5.7,+,1.05,5.05E-01
lipid modification (GO:0030258),31,6,5.7,+,1.05,5.05E-01
purine nucleotide biosynthetic process (GO:0006164),57,11,10.47,+,1.05,4.76E-01
positive regulation of nitrogen compound metabolic process (GO:0051173),166,32,30.51,+,1.05,4.17E-01
lipid metabolic process (GO:0006629),83,16,15.25,+,1.05,4.58E-01
cellular localization (GO:0051641),348,67,63.95,+,1.05,3.65E-01
aerobic respiration (GO:0009060),26,5,4.78,+,1.05,5.20E-01
regulation of chromosome organization (GO:0033044),26,5,4.78,+,1.05,5.20E-01
cellular protein metabolic process (GO:0044267),558,107,102.54,+,1.04,3.36E-01
vesicle-mediated transport (GO:0016192),209,40,38.41,+,1.04,4.19E-01
cellular protein modification process (GO:0006464),361,69,66.34,+,1.04,3.86E-01
protein modification process (GO:0036211),361,69,66.34,+,1.04,3.86E-01
positive regulation of gene expression (GO:0010628),105,20,19.3,+,1.04,4.67E-01
establishment of localization in cell (GO:0051649),294,56,54.03,+,1.04,4.11E-01
organelle disassembly (GO:1903008),21,4,3.86,+,1.04,5.39E-01
protein deubiquitination (GO:0016579),21,4,3.86,+,1.04,5.39E-01
response to organonitrogen compound (GO:0010243),21,4,3.86,+,1.04,5.39E-01
response to oxygen-containing compound (GO:1901700),21,4,3.86,+,1.04,5.39E-01
organic hydroxy compound biosynthetic process (GO:1901617),21,4,3.86,+,1.04,5.39E-01
endocytosis (GO:0006897),42,8,7.72,+,1.04,5.07E-01
regulation of cellular component organization (GO:0051128),100,19,18.38,+,1.03,4.73E-01
positive regulation of macromolecule biosynthetic process (GO:0010557),100,19,18.38,+,1.03,4.73E-01
ribonucleoprotein complex assembly (GO:0022618),58,11,10.66,+,1.03,4.99E-01
mRNA catabolic process (GO:0006402),37,7,6.8,+,1.03,5.20E-01
cellular response to stimulus (GO:0051716),516,97,94.82,+,1.02,4.23E-01
cellular metabolic process (GO:0044237),1745,328,320.68,+,1.02,3.24E-01
signaling (GO:0023052),415,78,76.26,+,1.02,4.35E-01
establishment of protein localization to vacuole (GO:0072666),16,3,2.94,+,1.02,5.64E-01
protein localization to vacuole (GO:0072665),16,3,2.94,+,1.02,5.64E-01
cellular response to oxygen-containing compound (GO:1901701),16,3,2.94,+,1.02,5.64E-01
vesicle fusion to plasma membrane (GO:0099500),32,6,5.88,+,1.02,5.35E-01
exocytic process (GO:0140029),32,6,5.88,+,1.02,5.35E-01
negative regulation of hydrolase activity (GO:0051346),16,3,2.94,+,1.02,5.64E-01
sphingolipid metabolic process (GO:0006665),16,3,2.94,+,1.02,5.64E-01
positive regulation of protein kinase activity (GO:0045860),16,3,2.94,+,1.02,5.64E-01
regulation of protein kinase activity (GO:0045859),32,6,5.88,+,1.02,5.35E-01
protein localization to endoplasmic reticulum (GO:0070972),16,3,2.94,+,1.02,5.64E-01
exocytosis (GO:0006887),32,6,5.88,+,1.02,5.35E-01
cellular calcium ion homeostasis (GO:0006874),16,3,2.94,+,1.02,5.64E-01
cellular process (GO:0009987),2826,529,519.33,+,1.02,2.89E-01
biological_process (GO:0008150),3059,572,562.15,+,1.02,2.86E-01
organelle organization (GO:0006996),610,114,112.1,+,1.02,4.39E-01
cell communication (GO:0007154),423,79,77.73,+,1.02,4.57E-01
metabolic process (GO:0008152),1845,344,339.05,+,1.01,3.84E-01
cellular component assembly (GO:0022607),258,48,47.41,+,1.01,4.86E-01
cellular component organization or biogenesis (GO:0071840),831,154,152.71,+,1.01,4.68E-01
response to abiotic stimulus (GO:0009628),27,5,4.96,+,1.01,5.53E-01
organic substance metabolic process (GO:0071704),1778,329,326.74,+,1.01,4.52E-01
catabolic process (GO:0009056),314,58,57.7,+,1.01,5.03E-01
heterocycle catabolic process (GO:0046700),65,12,11.95,+,1,5.33E-01
positive regulation of macromolecule metabolic process (GO:0010604),168,31,30.87,+,1,5.16E-01
intracellular signal transduction (GO:0035556),179,33,32.89,+,1,5.17E-01
positive regulation of protein modification process (GO:0031401),38,7,6.98,+,1,5.48E-01
regulation of mitotic cell cycle (GO:0007346),38,7,6.98,+,1,5.48E-01
ribonucleoprotein complex subunit organization (GO:0071826),60,11,11.03,-,1,5.76E-01
nitrogen compound metabolic process (GO:0006807),1632,299,299.91,-,1,4.91E-01
cellular nitrogen compound metabolic process (GO:0034641),1157,211,212.62,-,0.99,4.69E-01
primary metabolic process (GO:0044238),1662,303,305.42,-,0.99,4.50E-01
positive regulation of protein phosphorylation (GO:0001934),33,6,6.06,-,0.99,5.96E-01
regulation of mitotic sister chromatid separation (GO:0010965),11,2,2.02,-,0.99,6.71E-01
pigment metabolic process (GO:0042440),11,2,2.02,-,0.99,6.71E-01
protein methylation (GO:0006479),11,2,2.02,-,0.99,6.71E-01
pigment biosynthetic process (GO:0046148),11,2,2.02,-,0.99,6.71E-01
regulation of small GTPase mediated signal transduction (GO:0051056),11,2,2.02,-,0.99,6.71E-01
mRNA transport (GO:0051028),22,4,4.04,-,0.99,6.20E-01
regulation of cyclin-dependent protein kinase activity (GO:1904029),11,2,2.02,-,0.99,6.71E-01
regulation of autophagy (GO:0010506),11,2,2.02,-,0.99,6.71E-01
protein alkylation (GO:0008213),11,2,2.02,-,0.99,6.71E-01
double-strand break repair via break-induced replication (GO:0000727),11,2,2.02,-,0.99,6.71E-01
cation homeostasis (GO:0055080),44,8,8.09,-,0.99,5.81E-01
nucleosome organization (GO:0034728),22,4,4.04,-,0.99,6.20E-01
endosome transport via multivesicular body sorting pathway (GO:0032509),11,2,2.02,-,0.99,6.71E-01
ion homeostasis (GO:0050801),44,8,8.09,-,0.99,5.81E-01
fatty acid biosynthetic process (GO:0006633),11,2,2.02,-,0.99,6.71E-01
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),11,2,2.02,-,0.99,6.71E-01
metaphase/anaphase transition of mitotic cell cycle (GO:0007091),11,2,2.02,-,0.99,6.71E-01
regulation of metaphase/anaphase transition of cell cycle (GO:1902099),11,2,2.02,-,0.99,6.71E-01
cell fate specification (GO:0001708),11,2,2.02,-,0.99,6.71E-01
organic substance catabolic process (GO:1901575),270,49,49.62,-,0.99,5.02E-01
organic cyclic compound catabolic process (GO:1901361),72,13,13.23,-,0.98,5.47E-01
Unclassified (UNCLASSIFIED),2905,524,533.85,-,0.98,2.86E-01
chemical homeostasis (GO:0048878),50,9,9.19,-,0.98,5.62E-01
cytoskeleton organization (GO:0007010),162,29,29.77,-,0.97,4.92E-01
ribonucleoprotein complex localization (GO:0071166),28,5,5.15,-,0.97,5.90E-01
ribonucleoprotein complex export from nucleus (GO:0071426),28,5,5.15,-,0.97,5.90E-01
cellular catabolic process (GO:0044248),269,48,49.43,-,0.97,4.55E-01
response to stimulus (GO:0050896),600,107,110.26,-,0.97,3.96E-01
positive regulation of cellular metabolic process (GO:0031325),186,33,34.18,-,0.97,4.64E-01
cellular protein-containing complex assembly (GO:0034622),158,28,29.04,-,0.96,4.72E-01
positive regulation of RNA metabolic process (GO:0051254),96,17,17.64,-,0.96,5.02E-01
autophagy of mitochondrion (GO:0000422),17,3,3.12,-,0.96,6.19E-01
cell death (GO:0008219),34,6,6.25,-,0.96,5.66E-01
calcium ion homeostasis (GO:0055074),17,3,3.12,-,0.96,6.19E-01
membrane fission (GO:0090148),17,3,3.12,-,0.96,6.19E-01
receptor-mediated endocytosis (GO:0006898),17,3,3.12,-,0.96,6.19E-01
macromolecule metabolic process (GO:0043170),1490,262,273.82,-,0.96,2.16E-01
organelle localization (GO:0051640),74,13,13.6,-,0.96,5.07E-01
mRNA metabolic process (GO:0016071),131,23,24.07,-,0.96,4.66E-01
positive regulation of cellular protein metabolic process (GO:0032270),57,10,10.47,-,0.95,5.24E-01
cell morphogenesis (GO:0000902),57,10,10.47,-,0.95,5.24E-01
secretion by cell (GO:0032940),40,7,7.35,-,0.95,5.46E-01
secretion (GO:0046903),40,7,7.35,-,0.95,5.46E-01
regulation of biological process (GO:0050789),1265,221,232.47,-,0.95,2.10E-01
cellular nitrogen compound catabolic process (GO:0044270),63,11,11.58,-,0.95,5.10E-01
positive regulation of metabolic process (GO:0009893),195,34,35.84,-,0.95,4.20E-01
activation of adenylate cyclase activity (GO:0007190),23,4,4.23,-,0.95,5.85E-01
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),23,4,4.23,-,0.95,5.85E-01
response to nitrogen compound (GO:1901698),23,4,4.23,-,0.95,5.85E-01
positive regulation of nucleic acid-templated transcription (GO:1903508),92,16,16.91,-,0.95,4.76E-01
cellular divalent inorganic cation homeostasis (GO:0072503),23,4,4.23,-,0.95,5.85E-01
"positive regulation of transcription, DNA-templated (GO:0045893)",92,16,16.91,-,0.95,4.76E-01
positive regulation of RNA biosynthetic process (GO:1902680),92,16,16.91,-,0.95,4.76E-01
regulation of transport (GO:0051049),52,9,9.56,-,0.94,5.14E-01
biological regulation (GO:0065007),1372,237,252.13,-,0.94,1.47E-01
gene expression (GO:0010467),938,162,172.38,-,0.94,2.07E-01
cellular macromolecule metabolic process (GO:0044260),1246,215,228.98,-,0.94,1.58E-01
regulation of developmental process (GO:0050793),29,5,5.33,-,0.94,5.58E-01
positive regulation of protein metabolic process (GO:0051247),64,11,11.76,-,0.94,4.89E-01
chromatin organization (GO:0006325),99,17,18.19,-,0.93,4.50E-01
divalent metal ion transport (GO:0070838),35,6,6.43,-,0.93,5.37E-01
aromatic compound catabolic process (GO:0019439),70,12,12.86,-,0.93,4.78E-01
divalent inorganic cation transport (GO:0072511),35,6,6.43,-,0.93,5.37E-01
heterocycle metabolic process (GO:0046483),1021,175,187.63,-,0.93,1.65E-01
metal ion transport (GO:0030001),111,19,20.4,-,0.93,4.34E-01
organic cyclic compound metabolic process (GO:1901360),1029,176,189.1,-,0.93,1.57E-01
positive regulation of cellular process (GO:0048522),240,41,44.1,-,0.93,3.52E-01
regulation of phosphorus metabolic process (GO:0051174),82,14,15.07,-,0.93,4.58E-01
regulation of phosphate metabolic process (GO:0019220),82,14,15.07,-,0.93,4.58E-01
cellular cation homeostasis (GO:0030003),41,7,7.53,-,0.93,5.19E-01
regulation of protein metabolic process (GO:0051246),123,21,22.6,-,0.93,4.20E-01
protein-containing complex assembly (GO:0065003),164,28,30.14,-,0.93,3.91E-01
cellular ion homeostasis (GO:0006873),41,7,7.53,-,0.93,5.19E-01
organic substance biosynthetic process (GO:1901576),938,160,172.38,-,0.93,1.62E-01
biosynthetic process (GO:0009058),939,160,172.56,-,0.93,1.59E-01
cellular aromatic compound metabolic process (GO:0006725),1023,174,188,-,0.93,1.39E-01
nucleobase-containing compound metabolic process (GO:0006139),1000,170,183.77,-,0.93,1.41E-01
cellular component organization (GO:0016043),777,132,142.79,-,0.92,1.78E-01
regulation of cellular process (GO:0050794),1201,204,220.71,-,0.92,1.10E-01
microtubule-based process (GO:0007017),118,20,21.68,-,0.92,4.11E-01
cellular biosynthetic process (GO:0044249),928,157,170.54,-,0.92,1.38E-01
cell cycle (GO:0007049),148,25,27.2,-,0.92,3.81E-01
proteolysis (GO:0006508),220,37,40.43,-,0.92,3.26E-01
response to stress (GO:0006950),197,33,36.2,-,0.91,3.32E-01
supramolecular fiber organization (GO:0097435),78,13,14.33,-,0.91,4.29E-01
cellular response to chemical stimulus (GO:0070887),78,13,14.33,-,0.91,4.29E-01
endomembrane system organization (GO:0010256),36,6,6.62,-,0.91,5.08E-01
regulation of cellular protein metabolic process (GO:0032268),114,19,20.95,-,0.91,3.87E-01
cellular chemical homeostasis (GO:0055082),42,7,7.72,-,0.91,4.93E-01
positive regulation of biological process (GO:0048518),252,42,46.31,-,0.91,2.89E-01
actin filament organization (GO:0007015),54,9,9.92,-,0.91,4.67E-01
animal organ morphogenesis (GO:0009887),18,3,3.31,-,0.91,5.79E-01
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),6,1,1.1,-,0.91,6.98E-01
positive regulation of actin filament polymerization (GO:0030838),12,2,2.21,-,0.91,6.21E-01
mitochondrial fission (GO:0000266),6,1,1.1,-,0.91,6.98E-01
spliceosomal complex assembly (GO:0000245),6,1,1.1,-,0.91,6.98E-01
tRNA processing (GO:0008033),6,1,1.1,-,0.91,6.98E-01
positive regulation of organelle organization (GO:0010638),24,4,4.41,-,0.91,5.49E-01
purine nucleobase biosynthetic process (GO:0009113),6,1,1.1,-,0.91,6.98E-01
regulation of dephosphorylation (GO:0035303),6,1,1.1,-,0.91,6.98E-01
germ cell development (GO:0007281),6,1,1.1,-,0.91,6.98E-01
I-kappaB kinase/NF-kappaB signaling (GO:0007249),6,1,1.1,-,0.91,6.98E-01
negative regulation of Wnt signaling pathway (GO:0030178),6,1,1.1,-,0.91,6.98E-01
neuropeptide signaling pathway (GO:0007218),6,1,1.1,-,0.91,6.98E-01
"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",6,1,1.1,-,0.91,6.98E-01
signal peptide processing (GO:0006465),6,1,1.1,-,0.91,6.98E-01
regulation of chromosome separation (GO:1905818),12,2,2.21,-,0.91,6.21E-01
regulation of endocytosis (GO:0030100),6,1,1.1,-,0.91,6.98E-01
heart development (GO:0007507),6,1,1.1,-,0.91,6.98E-01
circulatory system development (GO:0072359),6,1,1.1,-,0.91,6.98E-01
microtubule cytoskeleton organization involved in mitosis (GO:1902850),12,2,2.21,-,0.91,6.21E-01
regulation of transmembrane transporter activity (GO:0022898),6,1,1.1,-,0.91,6.98E-01
positive regulation of developmental process (GO:0051094),6,1,1.1,-,0.91,6.98E-01
positive regulation of NF-kappaB transcription factor activity (GO:0051092),6,1,1.1,-,0.91,6.98E-01
regulation of cation transmembrane transport (GO:1904062),6,1,1.1,-,0.91,6.98E-01
cleavage involved in rRNA processing (GO:0000469),6,1,1.1,-,0.91,6.98E-01
regulation of mitotic sister chromatid segregation (GO:0033047),12,2,2.21,-,0.91,6.21E-01
cell-matrix adhesion (GO:0007160),6,1,1.1,-,0.91,6.98E-01
lipid oxidation (GO:0034440),6,1,1.1,-,0.91,6.98E-01
mitotic sister chromatid separation (GO:0051306),12,2,2.21,-,0.91,6.21E-01
cell cycle G2/M phase transition (GO:0044839),12,2,2.21,-,0.91,6.21E-01
regulation of microtubule polymerization or depolymerization (GO:0031110),6,1,1.1,-,0.91,6.98E-01
transition metal ion homeostasis (GO:0055076),12,2,2.21,-,0.91,6.21E-01
cellular monovalent inorganic cation homeostasis (GO:0030004),12,2,2.21,-,0.91,6.21E-01
positive regulation of stress-activated MAPK cascade (GO:0032874),6,1,1.1,-,0.91,6.98E-01
regulation of cell cycle G2/M phase transition (GO:1902749),12,2,2.21,-,0.91,6.21E-01
fatty acid beta-oxidation (GO:0006635),6,1,1.1,-,0.91,6.98E-01
G2/M transition of mitotic cell cycle (GO:0000086),12,2,2.21,-,0.91,6.21E-01
DNA damage checkpoint (GO:0000077),12,2,2.21,-,0.91,6.21E-01
regulation of JNK cascade (GO:0046328),6,1,1.1,-,0.91,6.98E-01
phospholipid transport (GO:0015914),6,1,1.1,-,0.91,6.98E-01
inorganic anion transmembrane transport (GO:0098661),6,1,1.1,-,0.91,6.98E-01
divalent inorganic cation homeostasis (GO:0072507),24,4,4.41,-,0.91,5.49E-01
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),6,1,1.1,-,0.91,6.98E-01
positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),6,1,1.1,-,0.91,6.98E-01
metaphase/anaphase transition of cell cycle (GO:0044784),12,2,2.21,-,0.91,6.21E-01
mitotic DNA integrity checkpoint (GO:0044774),12,2,2.21,-,0.91,6.21E-01
nucleotide-sugar metabolic process (GO:0009225),6,1,1.1,-,0.91,6.98E-01
negative regulation of cell death (GO:0060548),6,1,1.1,-,0.91,6.98E-01
meiosis I cell cycle process (GO:0061982),12,2,2.21,-,0.91,6.21E-01
cellular transition metal ion homeostasis (GO:0046916),12,2,2.21,-,0.91,6.21E-01
microtubule depolymerization (GO:0007019),6,1,1.1,-,0.91,6.98E-01
DNA unwinding involved in DNA replication (GO:0006268),6,1,1.1,-,0.91,6.98E-01
cellular carbohydrate biosynthetic process (GO:0034637),6,1,1.1,-,0.91,6.98E-01
regulation of ion transmembrane transporter activity (GO:0032412),6,1,1.1,-,0.91,6.98E-01
regulation of transporter activity (GO:0032409),6,1,1.1,-,0.91,6.98E-01
regulation of G2/M transition of mitotic cell cycle (GO:0010389),12,2,2.21,-,0.91,6.21E-01
meiotic chromosome segregation (GO:0045132),12,2,2.21,-,0.91,6.21E-01
cellular response to stress (GO:0033554),169,28,31.06,-,0.9,3.29E-01
Golgi vesicle transport (GO:0048193),85,14,15.62,-,0.9,4.03E-01
response to organic substance (GO:0010033),73,12,13.42,-,0.89,4.17E-01
cation transmembrane transport (GO:0098655),134,22,24.63,-,0.89,3.42E-01
nucleobase-containing compound catabolic process (GO:0034655),61,10,11.21,-,0.89,4.34E-01
organonitrogen compound catabolic process (GO:1901565),171,28,31.42,-,0.89,3.06E-01
protein-containing complex localization (GO:0031503),55,9,10.11,-,0.89,4.44E-01
protein-containing complex subunit organization (GO:0043933),196,32,36.02,-,0.89,2.81E-01
cellular macromolecule catabolic process (GO:0044265),178,29,32.71,-,0.89,2.91E-01
inorganic ion homeostasis (GO:0098771),43,7,7.9,-,0.89,4.66E-01
export from cell (GO:0140352),43,7,7.9,-,0.89,4.66E-01
protein acylation (GO:0043543),37,6,6.8,-,0.88,4.80E-01
RNA export from nucleus (GO:0006405),37,6,6.8,-,0.88,4.80E-01
cell surface receptor signaling pathway (GO:0007166),111,18,20.4,-,0.88,3.47E-01
RNA metabolic process (GO:0016070),810,131,148.85,-,0.88,6.11E-02
meiotic cell cycle process (GO:1903046),31,5,5.7,-,0.88,4.95E-01
macroautophagy (GO:0016236),31,5,5.7,-,0.88,4.95E-01
meiotic nuclear division (GO:0140013),31,5,5.7,-,0.88,4.95E-01
meiotic cell cycle (GO:0051321),31,5,5.7,-,0.88,4.95E-01
protein export from nucleus (GO:0006611),31,5,5.7,-,0.88,4.95E-01
cellular macromolecule biosynthetic process (GO:0034645),775,125,142.42,-,0.88,6.23E-02
cellular nitrogen compound biosynthetic process (GO:0044271),831,134,152.71,-,0.88,5.42E-02
macromolecule biosynthetic process (GO:0009059),776,125,142.6,-,0.88,6.03E-02
regulation of macromolecule metabolic process (GO:0060255),784,126,144.08,-,0.87,5.61E-02
positive regulation of phosphorus metabolic process (GO:0010562),56,9,10.29,-,0.87,4.21E-01
positive regulation of phosphate metabolic process (GO:0045937),56,9,10.29,-,0.87,4.21E-01
positive regulation of catalytic activity (GO:0043085),56,9,10.29,-,0.87,4.21E-01
regulation of metabolic process (GO:0019222),823,132,151.24,-,0.87,4.84E-02
protein catabolic process (GO:0030163),131,21,24.07,-,0.87,3.06E-01
regulation of phosphorylation (GO:0042325),75,12,13.78,-,0.87,3.79E-01
glycosylation (GO:0070085),25,4,4.59,-,0.87,5.14E-01
homeostatic process (GO:0042592),75,12,13.78,-,0.87,3.79E-01
microtubule cytoskeleton organization (GO:0000226),82,13,15.07,-,0.86,3.55E-01
nucleic acid metabolic process (GO:0090304),909,144,167.05,-,0.86,2.73E-02
protein localization to cilium (GO:0061512),19,3,3.49,-,0.86,5.38E-01
small GTPase mediated signal transduction (GO:0007264),19,3,3.49,-,0.86,5.38E-01
negative regulation of cellular protein metabolic process (GO:0032269),38,6,6.98,-,0.86,4.52E-01
regulation of GTPase activity (GO:0043087),19,3,3.49,-,0.86,5.38E-01
negative regulation of protein metabolic process (GO:0051248),38,6,6.98,-,0.86,4.52E-01
positive regulation of protein-containing complex assembly (GO:0031334),19,3,3.49,-,0.86,5.38E-01
regulation of gene expression (GO:0010468),685,108,125.88,-,0.86,4.75E-02
multicellular organismal process (GO:0032501),267,42,49.07,-,0.86,1.69E-01
locomotion (GO:0040011),51,8,9.37,-,0.85,4.07E-01
regulation of cellular amide metabolic process (GO:0034248),32,5,5.88,-,0.85,4.65E-01
regulation of localization (GO:0032879),64,10,11.76,-,0.85,3.72E-01
cellular metal ion homeostasis (GO:0006875),32,5,5.88,-,0.85,4.65E-01
anatomical structure morphogenesis (GO:0009653),109,17,20.03,-,0.85,2.93E-01
regulation of primary metabolic process (GO:0080090),725,113,133.23,-,0.85,3.19E-02
regulation of nucleobase-containing compound metabolic process (GO:0019219),610,95,112.1,-,0.85,4.65E-02
inorganic ion transmembrane transport (GO:0098660),135,21,24.81,-,0.85,2.57E-01
regulation of nitrogen compound metabolic process (GO:0051171),720,112,132.31,-,0.85,3.09E-02
microtubule-based movement (GO:0007018),58,9,10.66,-,0.84,3.78E-01
regulation of cellular metabolic process (GO:0031323),756,117,138.93,-,0.84,2.39E-02
inorganic cation transmembrane transport (GO:0098662),130,20,23.89,-,0.84,2.47E-01
nuclear export (GO:0051168),39,6,7.17,-,0.84,4.25E-01
glycoprotein biosynthetic process (GO:0009101),26,4,4.78,-,0.84,4.80E-01
signal release (GO:0023061),13,2,2.39,-,0.84,5.72E-01
negative regulation of endopeptidase activity (GO:0010951),13,2,2.39,-,0.84,5.72E-01
macromolecule catabolic process (GO:0009057),195,30,35.84,-,0.84,1.84E-01
establishment of protein localization to extracellular region (GO:0035592),13,2,2.39,-,0.84,5.72E-01
regulation of transferase activity (GO:0051338),52,8,9.56,-,0.84,3.84E-01
positive regulation of protein polymerization (GO:0032273),13,2,2.39,-,0.84,5.72E-01
chromatin assembly (GO:0031497),13,2,2.39,-,0.84,5.72E-01
monovalent inorganic cation homeostasis (GO:0055067),13,2,2.39,-,0.84,5.72E-01
regulation of protein localization (GO:0032880),13,2,2.39,-,0.84,5.72E-01
cellular response to hormone stimulus (GO:0032870),13,2,2.39,-,0.84,5.72E-01
negative regulation of catalytic activity (GO:0043086),26,4,4.78,-,0.84,4.80E-01
negative regulation of peptidase activity (GO:0010466),13,2,2.39,-,0.84,5.72E-01
regulation of mitotic nuclear division (GO:0007088),13,2,2.39,-,0.84,5.72E-01
negative regulation of proteolysis (GO:0045861),13,2,2.39,-,0.84,5.72E-01
protein localization to extracellular region (GO:0071692),13,2,2.39,-,0.84,5.72E-01
sodium ion transport (GO:0006814),52,8,9.56,-,0.84,3.84E-01
heterocycle biosynthetic process (GO:0018130),723,111,132.87,-,0.84,2.20E-02
cellular protein catabolic process (GO:0044257),124,19,22.79,-,0.83,2.49E-01
proteolysis involved in cellular protein catabolic process (GO:0051603),124,19,22.79,-,0.83,2.49E-01
organic cyclic compound biosynthetic process (GO:1901362),726,111,133.42,-,0.83,1.95E-02
aromatic compound biosynthetic process (GO:0019438),722,110,132.68,-,0.83,1.81E-02
protein-DNA complex subunit organization (GO:0071824),46,7,8.45,-,0.83,3.91E-01
peptidyl-lysine modification (GO:0018205),46,7,8.45,-,0.83,3.91E-01
regulation of catalytic activity (GO:0050790),132,20,24.26,-,0.82,2.24E-01
nucleobase-containing compound biosynthetic process (GO:0034654),708,107,130.11,-,0.82,1.55E-02
nuclear transport (GO:0051169),53,8,9.74,-,0.82,3.62E-01
cellular homeostasis (GO:0019725),53,8,9.74,-,0.82,3.62E-01
nucleocytoplasmic transport (GO:0006913),53,8,9.74,-,0.82,3.62E-01
modification-dependent protein catabolic process (GO:0019941),113,17,20.77,-,0.82,2.40E-01
regulation of hydrolase activity (GO:0051336),40,6,7.35,-,0.82,3.98E-01
chromosome separation (GO:0051304),20,3,3.68,-,0.82,4.99E-01
cell fate commitment (GO:0045165),20,3,3.68,-,0.82,4.99E-01
mRNA processing (GO:0006397),100,15,18.38,-,0.82,2.56E-01
regulation of biological quality (GO:0065008),174,26,31.98,-,0.81,1.63E-01
regulation of RNA metabolic process (GO:0051252),597,89,109.71,-,0.81,1.87E-02
regulation of cellular biosynthetic process (GO:0031326),600,89,110.26,-,0.81,1.64E-02
regulation of proteolysis (GO:0030162),27,4,4.96,-,0.81,4.47E-01
regulation of cellular catabolic process (GO:0031329),27,4,4.96,-,0.81,4.47E-01
regulation of biosynthetic process (GO:0009889),601,89,110.45,-,0.81,1.57E-02
transcription by RNA polymerase II (GO:0006366),482,71,88.58,-,0.8,2.64E-02
RNA biosynthetic process (GO:0032774),598,88,109.89,-,0.8,1.37E-02
metal ion homeostasis (GO:0055065),34,5,6.25,-,0.8,4.06E-01
positive regulation of molecular function (GO:0044093),68,10,12.5,-,0.8,2.96E-01
nucleic acid-templated transcription (GO:0097659),593,87,108.98,-,0.8,1.31E-02
"transcription, DNA-templated (GO:0006351)",593,87,108.98,-,0.8,1.31E-02
"mRNA splicing, via spliceosome (GO:0000398)",75,11,13.78,-,0.8,2.77E-01
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",75,11,13.78,-,0.8,2.77E-01
"RNA splicing, via transesterification reactions (GO:0000375)",75,11,13.78,-,0.8,2.77E-01
reproductive process (GO:0022414),41,6,7.53,-,0.8,3.73E-01
regulation of cellular macromolecule biosynthetic process (GO:2000112),596,87,109.53,-,0.79,1.14E-02
regulation of macromolecule biosynthetic process (GO:0010556),597,87,109.71,-,0.79,1.09E-02
response to chemical (GO:0042221),158,23,29.04,-,0.79,1.48E-01
modification-dependent macromolecule catabolic process (GO:0043632),117,17,21.5,-,0.79,1.94E-01
cellular response to organic substance (GO:0071310),62,9,11.39,-,0.79,2.98E-01
cell development (GO:0048468),69,10,12.68,-,0.79,2.79E-01
cellular response to DNA damage stimulus (GO:0006974),97,14,17.83,-,0.79,2.18E-01
nervous system development (GO:0007399),104,15,19.11,-,0.78,2.05E-01
"regulation of transcription, DNA-templated (GO:0006355)",558,80,102.54,-,0.78,9.32E-03
regulation of nucleic acid-templated transcription (GO:1903506),558,80,102.54,-,0.78,9.32E-03
regulation of RNA biosynthetic process (GO:2001141),558,80,102.54,-,0.78,9.32E-03
positive regulation of cellular component organization (GO:0051130),35,5,6.43,-,0.78,3.78E-01
posttranscriptional regulation of gene expression (GO:0010608),42,6,7.72,-,0.78,3.48E-01
neuron differentiation (GO:0030182),70,10,12.86,-,0.78,2.62E-01
mRNA export from nucleus (GO:0006406),21,3,3.86,-,0.78,4.61E-01
transition metal ion transport (GO:0000041),21,3,3.86,-,0.78,4.61E-01
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),21,3,3.86,-,0.78,4.61E-01
DNA metabolic process (GO:0006259),126,18,23.15,-,0.78,1.64E-01
calcium ion transport (GO:0006816),21,3,3.86,-,0.78,4.61E-01
regulation of microtubule cytoskeleton organization (GO:0070507),7,1,1.29,-,0.78,6.32E-01
epithelium development (GO:0060429),7,1,1.29,-,0.78,6.32E-01
positive regulation of GTPase activity (GO:0043547),14,2,2.57,-,0.78,5.25E-01
neurotransmitter secretion (GO:0007269),7,1,1.29,-,0.78,6.32E-01
JNK cascade (GO:0007254),7,1,1.29,-,0.78,6.32E-01
ubiquitin-dependent ERAD pathway (GO:0030433),7,1,1.29,-,0.78,6.32E-01
monocarboxylic acid biosynthetic process (GO:0072330),14,2,2.57,-,0.78,5.25E-01
regulation of sister chromatid segregation (GO:0033045),14,2,2.57,-,0.78,5.25E-01
regulation of chromosome segregation (GO:0051983),14,2,2.57,-,0.78,5.25E-01
synapse assembly (GO:0007416),7,1,1.29,-,0.78,6.32E-01
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),7,1,1.29,-,0.78,6.32E-01
postreplication repair (GO:0006301),7,1,1.29,-,0.78,6.32E-01
chaperone-mediated protein folding (GO:0061077),14,2,2.57,-,0.78,5.25E-01
muscle structure development (GO:0061061),7,1,1.29,-,0.78,6.32E-01
regulation of mitotic cell cycle phase transition (GO:1901990),28,4,5.15,-,0.78,4.15E-01
"positive regulation of DNA-templated transcription, initiation (GO:2000144)",7,1,1.29,-,0.78,6.32E-01
cilium movement (GO:0003341),7,1,1.29,-,0.78,6.32E-01
"regulation of DNA-templated transcription, initiation (GO:2000142)",7,1,1.29,-,0.78,6.32E-01
gene silencing by miRNA (GO:0035195),7,1,1.29,-,0.78,6.32E-01
very long-chain fatty acid metabolic process (GO:0000038),7,1,1.29,-,0.78,6.32E-01
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),7,1,1.29,-,0.78,6.32E-01
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),7,1,1.29,-,0.78,6.32E-01
centrosome cycle (GO:0007098),7,1,1.29,-,0.78,6.32E-01
calcium-ion regulated exocytosis (GO:0017156),7,1,1.29,-,0.78,6.32E-01
stress-activated protein kinase signaling cascade (GO:0031098),14,2,2.57,-,0.78,5.25E-01
histone H3-K4 methylation (GO:0051568),7,1,1.29,-,0.78,6.32E-01
mismatch repair (GO:0006298),7,1,1.29,-,0.78,6.32E-01
cellular zinc ion homeostasis (GO:0006882),7,1,1.29,-,0.78,6.32E-01
negative regulation of molecular function (GO:0044092),28,4,5.15,-,0.78,4.15E-01
response to metal ion (GO:0010038),7,1,1.29,-,0.78,6.32E-01
signal release from synapse (GO:0099643),7,1,1.29,-,0.78,6.32E-01
regulation of transcription by RNA polymerase II (GO:0006357),457,65,83.98,-,0.77,1.54E-02
negative regulation of biological process (GO:0048519),233,33,42.82,-,0.77,6.90E-02
generation of neurons (GO:0048699),78,11,14.33,-,0.77,2.31E-01
movement of cell or subcellular component (GO:0006928),114,16,20.95,-,0.76,1.63E-01
regulation of molecular function (GO:0065009),150,21,27.57,-,0.76,1.18E-01
anatomical structure development (GO:0048856),229,32,42.08,-,0.76,6.15E-02
DNA repair (GO:0006281),86,12,15.8,-,0.76,2.04E-01
regulation of cyclase activity (GO:0031279),36,5,6.62,-,0.76,3.52E-01
regulation of cell cycle process (GO:0010564),36,5,6.62,-,0.76,3.52E-01
positive regulation of transferase activity (GO:0051347),36,5,6.62,-,0.76,3.52E-01
regulation of lyase activity (GO:0051339),36,5,6.62,-,0.76,3.52E-01
ubiquitin-dependent protein catabolic process (GO:0006511),108,15,19.85,-,0.76,1.62E-01
developmental process (GO:0032502),267,37,49.07,-,0.75,4.12E-02
regulation of cell cycle phase transition (GO:1901987),29,4,5.33,-,0.75,3.84E-01
chromosome organization (GO:0051276),160,22,29.4,-,0.75,9.44E-02
regulation of kinase activity (GO:0043549),51,7,9.37,-,0.75,2.81E-01
cell division (GO:0051301),22,3,4.04,-,0.74,4.25E-01
nervous system process (GO:0050877),88,12,16.17,-,0.74,1.80E-01
"regulation of gene expression, epigenetic (GO:0040029)",22,3,4.04,-,0.74,4.25E-01
tissue development (GO:0009888),22,3,4.04,-,0.74,4.25E-01
positive regulation of cellular component biogenesis (GO:0044089),22,3,4.04,-,0.74,4.25E-01
neurogenesis (GO:0022008),81,11,14.89,-,0.74,1.91E-01
regulation of protein-containing complex assembly (GO:0043254),37,5,6.8,-,0.74,3.26E-01
establishment of organelle localization (GO:0051656),52,7,9.56,-,0.73,2.62E-01
positive regulation of supramolecular fiber organization (GO:1902905),15,2,2.76,-,0.73,4.80E-01
calcium ion transmembrane transport (GO:0070588),15,2,2.76,-,0.73,4.80E-01
positive regulation of cytoskeleton organization (GO:0051495),15,2,2.76,-,0.73,4.80E-01
regulation of endopeptidase activity (GO:0052548),15,2,2.76,-,0.73,4.80E-01
regulation of peptidase activity (GO:0052547),15,2,2.76,-,0.73,4.80E-01
regulation of translation (GO:0006417),30,4,5.51,-,0.73,3.55E-01
telomere maintenance (GO:0000723),15,2,2.76,-,0.73,4.80E-01
cell projection assembly (GO:0030031),30,4,5.51,-,0.73,3.55E-01
telomere organization (GO:0032200),15,2,2.76,-,0.73,4.80E-01
response to oxidative stress (GO:0006979),15,2,2.76,-,0.73,4.80E-01
anatomical structure homeostasis (GO:0060249),15,2,2.76,-,0.73,4.80E-01
protein depolymerization (GO:0051261),15,2,2.76,-,0.73,4.80E-01
snRNA metabolic process (GO:0016073),15,2,2.76,-,0.73,4.80E-01
regulation of exocytosis (GO:0017157),15,2,2.76,-,0.73,4.80E-01
nucleotide-excision repair (GO:0006289),15,2,2.76,-,0.73,4.80E-01
sensory perception of chemical stimulus (GO:0007606),68,9,12.5,-,0.72,2.00E-01
sensory perception (GO:0007600),68,9,12.5,-,0.72,2.00E-01
multicellular organism development (GO:0007275),159,21,29.22,-,0.72,6.86E-02
RNA splicing (GO:0008380),84,11,15.44,-,0.71,1.56E-01
system process (GO:0003008),92,12,16.91,-,0.71,1.38E-01
regulation of cellular component biogenesis (GO:0044087),46,6,8.45,-,0.71,2.60E-01
positive regulation of phosphorylation (GO:0042327),54,7,9.92,-,0.71,2.26E-01
cell differentiation (GO:0030154),162,21,29.77,-,0.71,5.65E-02
cellular developmental process (GO:0048869),163,21,29.95,-,0.7,5.29E-02
cell cycle process (GO:0022402),132,17,24.26,-,0.7,7.72E-02
organelle fission (GO:0048285),125,16,22.97,-,0.7,8.07E-02
nuclear division (GO:0000280),118,15,21.68,-,0.69,8.44E-02
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),79,10,14.52,-,0.69,1.42E-01
system development (GO:0048731),127,16,23.34,-,0.69,7.03E-02
regulation of supramolecular fiber organization (GO:1902903),32,4,5.88,-,0.68,3.01E-01
regulation of establishment of protein localization (GO:0070201),8,1,1.47,-,0.68,5.68E-01
regulation of peptide transport (GO:0090087),8,1,1.47,-,0.68,5.68E-01
positive regulation of DNA-binding transcription factor activity (GO:0051091),8,1,1.47,-,0.68,5.68E-01
fatty acid catabolic process (GO:0009062),8,1,1.47,-,0.68,5.68E-01
protein autophosphorylation (GO:0046777),8,1,1.47,-,0.68,5.68E-01
taxis (GO:0042330),32,4,5.88,-,0.68,3.01E-01
mitotic G2/M transition checkpoint (GO:0044818),8,1,1.47,-,0.68,5.68E-01
actin filament depolymerization (GO:0030042),8,1,1.47,-,0.68,5.68E-01
microtubule polymerization or depolymerization (GO:0031109),16,2,2.94,-,0.68,4.36E-01
chromatin assembly or disassembly (GO:0006333),16,2,2.94,-,0.68,4.36E-01
anterior/posterior pattern specification (GO:0009952),16,2,2.94,-,0.68,4.36E-01
regulation of microtubule-based process (GO:0032886),8,1,1.47,-,0.68,5.68E-01
chemotaxis (GO:0006935),32,4,5.88,-,0.68,3.01E-01
purine nucleoside metabolic process (GO:0042278),8,1,1.47,-,0.68,5.68E-01
regulation of protein transport (GO:0051223),8,1,1.47,-,0.68,5.68E-01
mitotic DNA damage checkpoint (GO:0044773),8,1,1.47,-,0.68,5.68E-01
pteridine-containing compound metabolic process (GO:0042558),8,1,1.47,-,0.68,5.68E-01
actomyosin structure organization (GO:0031032),8,1,1.47,-,0.68,5.68E-01
regulation of canonical Wnt signaling pathway (GO:0060828),8,1,1.47,-,0.68,5.68E-01
protein-DNA complex assembly (GO:0065004),32,4,5.88,-,0.68,3.01E-01
protein sumoylation (GO:0016925),8,1,1.47,-,0.68,5.68E-01
negative regulation of macromolecule metabolic process (GO:0010605),153,19,28.12,-,0.68,4.38E-02
mitotic cell cycle (GO:0000278),106,13,19.48,-,0.67,7.97E-02
mitotic cell cycle process (GO:1903047),106,13,19.48,-,0.67,7.97E-02
mitotic nuclear division (GO:0140014),106,13,19.48,-,0.67,7.97E-02
regulation of cytoskeleton organization (GO:0051493),41,5,7.53,-,0.66,2.37E-01
regulation of catabolic process (GO:0009894),33,4,6.06,-,0.66,2.76E-01
DNA-dependent DNA replication (GO:0006261),33,4,6.06,-,0.66,2.76E-01
negative regulation of cellular process (GO:0048523),190,23,34.92,-,0.66,1.99E-02
negative regulation of metabolic process (GO:0009892),157,19,28.85,-,0.66,3.28E-02
proteasomal protein catabolic process (GO:0010498),83,10,15.25,-,0.66,1.05E-01
regulation of actin filament polymerization (GO:0030833),25,3,4.59,-,0.65,3.26E-01
import into nucleus (GO:0051170),25,3,4.59,-,0.65,3.26E-01
protein localization to nucleus (GO:0034504),25,3,4.59,-,0.65,3.26E-01
actin filament polymerization (GO:0030041),25,3,4.59,-,0.65,3.26E-01
protein import into nucleus (GO:0006606),25,3,4.59,-,0.65,3.26E-01
Wnt signaling pathway (GO:0016055),25,3,4.59,-,0.65,3.26E-01
DNA biosynthetic process (GO:0071897),42,5,7.72,-,0.65,2.17E-01
regulation of actin filament-based process (GO:0032970),34,4,6.25,-,0.64,2.52E-01
regulation of actin cytoskeleton organization (GO:0032956),34,4,6.25,-,0.64,2.52E-01
regulation of secretion (GO:0051046),17,2,3.12,-,0.64,3.96E-01
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),34,4,6.25,-,0.64,2.52E-01
positive regulation of hydrolase activity (GO:0051345),17,2,3.12,-,0.64,3.96E-01
RNA 3'-end processing (GO:0031123),34,4,6.25,-,0.64,2.52E-01
regulation of secretion by cell (GO:1903530),17,2,3.12,-,0.64,3.96E-01
cellular component disassembly (GO:0022411),51,6,9.37,-,0.64,1.74E-01
cellular protein complex disassembly (GO:0043624),17,2,3.12,-,0.64,3.96E-01
regulation of cAMP-mediated signaling (GO:0043949),34,4,6.25,-,0.64,2.52E-01
double-strand break repair (GO:0006302),43,5,7.9,-,0.63,1.99E-01
cell projection morphogenesis (GO:0048858),43,5,7.9,-,0.63,1.99E-01
neuron projection morphogenesis (GO:0048812),43,5,7.9,-,0.63,1.99E-01
plasma membrane bounded cell projection morphogenesis (GO:0120039),43,5,7.9,-,0.63,1.99E-01
cell morphogenesis involved in differentiation (GO:0000904),43,5,7.9,-,0.63,1.99E-01
histone acetylation (GO:0016573),26,3,4.78,-,0.63,2.97E-01
internal protein amino acid acetylation (GO:0006475),26,3,4.78,-,0.63,2.97E-01
peptidyl-lysine acetylation (GO:0018394),26,3,4.78,-,0.63,2.97E-01
internal peptidyl-lysine acetylation (GO:0018393),26,3,4.78,-,0.63,2.97E-01
cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114),26,3,4.78,-,0.63,2.97E-01
regulation of protein polymerization (GO:0032271),26,3,4.78,-,0.63,2.97E-01
cell-cell signaling by wnt (GO:0198738),26,3,4.78,-,0.63,2.97E-01
regulation of adenylate cyclase activity (GO:0045761),35,4,6.43,-,0.62,2.31E-01
response to endogenous stimulus (GO:0009719),35,4,6.43,-,0.62,2.31E-01
positive regulation of transcription by RNA polymerase II (GO:0045944),70,8,12.86,-,0.62,1.05E-01
positive regulation of kinase activity (GO:0033674),35,4,6.43,-,0.62,2.31E-01
cAMP-mediated signaling (GO:0019933),35,4,6.43,-,0.62,2.31E-01
cell part morphogenesis (GO:0032990),44,5,8.09,-,0.62,1.82E-01
detection of stimulus (GO:0051606),44,5,8.09,-,0.62,1.82E-01
histone modification (GO:0016570),53,6,9.74,-,0.62,1.46E-01
covalent chromatin modification (GO:0016569),53,6,9.74,-,0.62,1.46E-01
negative regulation of actin filament polymerization (GO:0030837),9,1,1.65,-,0.6,5.08E-01
regulation of actin filament length (GO:0030832),27,3,4.96,-,0.6,2.70E-01
cyclic nucleotide metabolic process (GO:0009187),9,1,1.65,-,0.6,5.08E-01
regulation of protein catabolic process (GO:0042176),18,2,3.31,-,0.6,3.57E-01
positive regulation of cell cycle (GO:0045787),9,1,1.65,-,0.6,5.08E-01
regulation of actin polymerization or depolymerization (GO:0008064),27,3,4.96,-,0.6,2.70E-01
"vesicle targeting, trans-Golgi to periciliary membrane compartment (GO:0097712)",18,2,3.31,-,0.6,3.57E-01
"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",9,1,1.65,-,0.6,5.08E-01
translational initiation (GO:0006413),9,1,1.65,-,0.6,5.08E-01
regulation of DNA-binding transcription factor activity (GO:0051090),9,1,1.65,-,0.6,5.08E-01
microtubule polymerization (GO:0046785),9,1,1.65,-,0.6,5.08E-01
microtubule bundle formation (GO:0001578),18,2,3.31,-,0.6,3.57E-01
protein prenylation (GO:0018342),9,1,1.65,-,0.6,5.08E-01
neuron projection development (GO:0031175),45,5,8.27,-,0.6,1.67E-01
regulation of vesicle-mediated transport (GO:0060627),27,3,4.96,-,0.6,2.70E-01
cell projection organization (GO:0030030),81,9,14.89,-,0.6,7.23E-02
nucleosome assembly (GO:0006334),9,1,1.65,-,0.6,5.08E-01
nucleus organization (GO:0006997),9,1,1.65,-,0.6,5.08E-01
cilium assembly (GO:0060271),18,2,3.31,-,0.6,3.57E-01
protein polymerization (GO:0051258),36,4,6.62,-,0.6,2.10E-01
ciliary transition zone assembly (GO:1905349),18,2,3.31,-,0.6,3.57E-01
aerobic electron transport chain (GO:0019646),9,1,1.65,-,0.6,5.08E-01
intraciliary transport involved in cilium assembly (GO:0035735),18,2,3.31,-,0.6,3.57E-01
histone lysine methylation (GO:0034968),9,1,1.65,-,0.6,5.08E-01
axoneme assembly (GO:0035082),18,2,3.31,-,0.6,3.57E-01
cellular component morphogenesis (GO:0032989),46,5,8.45,-,0.59,1.52E-01
neuron development (GO:0048666),46,5,8.45,-,0.59,1.52E-01
mitotic cell cycle phase transition (GO:0044772),37,4,6.8,-,0.59,1.91E-01
negative regulation of gene expression (GO:0010629),130,14,23.89,-,0.59,1.98E-02
protein acetylation (GO:0006473),28,3,5.15,-,0.58,2.45E-01
regulation of actin filament organization (GO:0110053),28,3,5.15,-,0.58,2.45E-01
actin polymerization or depolymerization (GO:0008154),28,3,5.15,-,0.58,2.45E-01
plasma membrane bounded cell projection assembly (GO:0120031),28,3,5.15,-,0.58,2.45E-01
mRNA 3'-end processing (GO:0031124),19,2,3.49,-,0.57,3.22E-01
cell cycle phase transition (GO:0044770),38,4,6.98,-,0.57,1.74E-01
DNA replication (GO:0006260),38,4,6.98,-,0.57,1.74E-01
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),38,4,6.98,-,0.57,1.74E-01
regulation of anatomical structure size (GO:0090066),29,3,5.33,-,0.56,2.21E-01
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),29,3,5.33,-,0.56,2.21E-01
regulation of cellular component size (GO:0032535),29,3,5.33,-,0.56,2.21E-01
axon development (GO:0061564),39,4,7.17,-,0.56,1.57E-01
axonogenesis (GO:0007409),39,4,7.17,-,0.56,1.57E-01
plasma membrane bounded cell projection organization (GO:0120036),79,8,14.52,-,0.55,4.69E-02
positive regulation of proteasomal protein catabolic process (GO:1901800),10,1,1.84,-,0.54,4.52E-01
protein transport along microtubule (GO:0098840),20,2,3.68,-,0.54,2.89E-01
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),10,1,1.84,-,0.54,4.52E-01
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),10,1,1.84,-,0.54,4.52E-01
regulation of cell population proliferation (GO:0042127),10,1,1.84,-,0.54,4.52E-01
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),10,1,1.84,-,0.54,4.52E-01
positive regulation of cellular protein catabolic process (GO:1903364),10,1,1.84,-,0.54,4.52E-01
histone methylation (GO:0016571),10,1,1.84,-,0.54,4.52E-01
nucleic acid phosphodiester bond hydrolysis (GO:0090305),30,3,5.51,-,0.54,2.00E-01
regulated exocytosis (GO:0045055),10,1,1.84,-,0.54,4.52E-01
cell morphogenesis involved in neuron differentiation (GO:0048667),40,4,7.35,-,0.54,1.42E-01
monocarboxylic acid catabolic process (GO:0072329),10,1,1.84,-,0.54,4.52E-01
positive regulation of transport (GO:0051050),10,1,1.84,-,0.54,4.52E-01
intraciliary transport (GO:0042073),20,2,3.68,-,0.54,2.89E-01
cytoskeleton-dependent intracellular transport (GO:0030705),40,4,7.35,-,0.54,1.42E-01
regulation of cellular localization (GO:0060341),20,2,3.68,-,0.54,2.89E-01
cell population proliferation (GO:0008283),10,1,1.84,-,0.54,4.52E-01
maintenance of location in cell (GO:0051651),10,1,1.84,-,0.54,4.52E-01
nucleobase-containing small molecule biosynthetic process (GO:0034404),10,1,1.84,-,0.54,4.52E-01
recombinational repair (GO:0000725),30,3,5.51,-,0.54,2.00E-01
double-strand break repair via homologous recombination (GO:0000724),30,3,5.51,-,0.54,2.00E-01
axon guidance (GO:0007411),30,3,5.51,-,0.54,2.00E-01
microtubule-based protein transport (GO:0099118),20,2,3.68,-,0.54,2.89E-01
developmental process involved in reproduction (GO:0003006),10,1,1.84,-,0.54,4.52E-01
ERAD pathway (GO:0036503),10,1,1.84,-,0.54,4.52E-01
microtubule organizing center organization (GO:0031023),10,1,1.84,-,0.54,4.52E-01
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),10,1,1.84,-,0.54,4.52E-01
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),10,1,1.84,-,0.54,4.52E-01
poly(A)+ mRNA export from nucleus (GO:0016973),10,1,1.84,-,0.54,4.52E-01
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),10,1,1.84,-,0.54,4.52E-01
regulation of ubiquitin-dependent protein catabolic process (GO:2000058),10,1,1.84,-,0.54,4.52E-01
response to inorganic substance (GO:0010035),10,1,1.84,-,0.54,4.52E-01
neuron projection guidance (GO:0097485),30,3,5.51,-,0.54,2.00E-01
neurotransmitter transport (GO:0006836),10,1,1.84,-,0.54,4.52E-01
DNA recombination (GO:0006310),41,4,7.53,-,0.53,1.29E-01
animal organ development (GO:0048513),31,3,5.7,-,0.53,1.80E-01
second-messenger-mediated signaling (GO:0019932),52,5,9.56,-,0.52,8.49E-02
protein glycosylation (GO:0006486),21,2,3.86,-,0.52,2.59E-01
"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",42,4,7.72,-,0.52,1.16E-01
macromolecule glycosylation (GO:0043413),21,2,3.86,-,0.52,2.59E-01
gene silencing (GO:0016458),21,2,3.86,-,0.52,2.59E-01
cell-cell signaling (GO:0007267),97,9,17.83,-,0.5,1.63E-02
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),11,1,2.02,-,0.49,4.00E-01
DNA geometric change (GO:0032392),11,1,2.02,-,0.49,4.00E-01
regulation of cellular protein catabolic process (GO:1903362),11,1,2.02,-,0.49,4.00E-01
carbohydrate derivative catabolic process (GO:1901136),22,2,4.04,-,0.49,2.31E-01
canonical Wnt signaling pathway (GO:0060070),22,2,4.04,-,0.49,2.31E-01
regulation of proteasomal protein catabolic process (GO:0061136),11,1,2.02,-,0.49,4.00E-01
regulation of neurotransmitter levels (GO:0001505),11,1,2.02,-,0.49,4.00E-01
DNA packaging (GO:0006323),22,2,4.04,-,0.49,2.31E-01
DNA duplex unwinding (GO:0032508),11,1,2.02,-,0.49,4.00E-01
vesicle targeting (GO:0006903),22,2,4.04,-,0.49,2.31E-01
Arp2/3 complex-mediated actin nucleation (GO:0034314),11,1,2.02,-,0.49,4.00E-01
"vesicle targeting, to, from or within Golgi (GO:0048199)",22,2,4.04,-,0.49,2.31E-01
cyclic-nucleotide-mediated signaling (GO:0019935),45,4,8.27,-,0.48,8.44E-02
cellular response to endogenous stimulus (GO:0071495),34,3,6.25,-,0.48,1.30E-01
DNA conformation change (GO:0071103),34,3,6.25,-,0.48,1.30E-01
protein-containing complex disassembly (GO:0032984),23,2,4.23,-,0.47,2.06E-01
cilium organization (GO:0044782),23,2,4.23,-,0.47,2.06E-01
negative regulation of cellular metabolic process (GO:0031324),115,10,21.13,-,0.47,5.46E-03
synapse organization (GO:0050808),35,3,6.43,-,0.47,1.16E-01
nuclear chromosome segregation (GO:0098813),36,3,6.62,-,0.45,1.03E-01
peptide secretion (GO:0002790),12,1,2.21,-,0.45,3.53E-01
protein N-linked glycosylation (GO:0006487),12,1,2.21,-,0.45,3.53E-01
enzyme linked receptor protein signaling pathway (GO:0007167),48,4,8.82,-,0.45,6.06E-02
protein secretion (GO:0009306),12,1,2.21,-,0.45,3.53E-01
positive regulation of proteolysis (GO:0045862),12,1,2.21,-,0.45,3.53E-01
cell junction assembly (GO:0034329),12,1,2.21,-,0.45,3.53E-01
pattern specification process (GO:0007389),24,2,4.41,-,0.45,1.83E-01
activation of protein kinase activity (GO:0032147),12,1,2.21,-,0.45,3.53E-01
negative regulation of nitrogen compound metabolic process (GO:0051172),109,9,20.03,-,0.45,4.62E-03
mitotic sister chromatid segregation (GO:0000070),25,2,4.59,-,0.44,1.63E-01
chemical synaptic transmission (GO:0007268),65,5,11.95,-,0.42,2.06E-02
trans-synaptic signaling (GO:0099537),65,5,11.95,-,0.42,2.06E-02
anterograde trans-synaptic signaling (GO:0098916),65,5,11.95,-,0.42,2.06E-02
transport along microtubule (GO:0010970),26,2,4.78,-,0.42,1.44E-01
'de novo' protein folding (GO:0006458),13,1,2.39,-,0.42,3.11E-01
cellular lipid catabolic process (GO:0044242),13,1,2.39,-,0.42,3.11E-01
microtubule-based transport (GO:0099111),26,2,4.78,-,0.42,1.44E-01
RNA phosphodiester bond hydrolysis (GO:0090501),13,1,2.39,-,0.42,3.11E-01
maintenance of location (GO:0051235),13,1,2.39,-,0.42,3.11E-01
chromosome segregation (GO:0007059),39,3,7.17,-,0.42,7.28E-02
organic hydroxy compound transport (GO:0015850),13,1,2.39,-,0.42,3.11E-01
synaptic signaling (GO:0099536),66,5,12.13,-,0.41,1.83E-02
cell junction organization (GO:0034330),42,3,7.72,-,0.39,5.06E-02
motor neuron axon guidance (GO:0008045),14,1,2.57,-,0.39,2.72E-01
amino sugar metabolic process (GO:0006040),14,1,2.57,-,0.39,2.72E-01
tRNA metabolic process (GO:0006399),14,1,2.57,-,0.39,2.72E-01
chromatin organization involved in regulation of transcription (GO:0034401),14,1,2.57,-,0.39,2.72E-01
mRNA polyadenylation (GO:0006378),14,1,2.57,-,0.39,2.72E-01
regulation of nervous system development (GO:0051960),14,1,2.57,-,0.39,2.72E-01
regulation of neurogenesis (GO:0050767),14,1,2.57,-,0.39,2.72E-01
lipid transport (GO:0006869),14,1,2.57,-,0.39,2.72E-01
sodium ion transmembrane transport (GO:0035725),44,3,8.09,-,0.37,3.95E-02
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",15,1,2.76,-,0.36,2.38E-01
regulation of cell development (GO:0060284),15,1,2.76,-,0.36,2.38E-01
DNA replication initiation (GO:0006270),15,1,2.76,-,0.36,2.38E-01
positive regulation of cellular catabolic process (GO:0031331),15,1,2.76,-,0.36,2.38E-01
sister chromatid segregation (GO:0000819),31,2,5.7,-,0.35,7.64E-02
positive regulation of protein catabolic process (GO:0045732),16,1,2.94,-,0.34,2.08E-01
"synaptic transmission, glutamatergic (GO:0035249)",16,1,2.94,-,0.34,2.08E-01
lipid localization (GO:0010876),16,1,2.94,-,0.34,2.08E-01
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),17,1,3.12,-,0.32,1.81E-01
negative regulation of translation (GO:0017148),17,1,3.12,-,0.32,1.81E-01
detection of chemical stimulus (GO:0009593),34,2,6.25,-,0.32,5.13E-02
negative regulation of macromolecule biosynthetic process (GO:0010558),90,5,16.54,-,0.3,8.83E-04
regulation of cell differentiation (GO:0045595),18,1,3.31,-,0.3,1.57E-01
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),90,5,16.54,-,0.3,8.83E-04
lipid catabolic process (GO:0016042),18,1,3.31,-,0.3,1.57E-01
regulation of multicellular organismal development (GO:2000026),18,1,3.31,-,0.3,1.57E-01
negative regulation of biosynthetic process (GO:0009890),92,5,16.91,-,0.3,6.75E-04
negative regulation of cellular biosynthetic process (GO:0031327),92,5,16.91,-,0.3,6.75E-04
negative regulation of transcription by RNA polymerase II (GO:0000122),37,2,6.8,-,0.29,3.41E-02
establishment of vesicle localization (GO:0051650),37,2,6.8,-,0.29,3.41E-02
vesicle localization (GO:0051648),37,2,6.8,-,0.29,3.41E-02
regulation of multicellular organismal process (GO:0051239),19,1,3.49,-,0.29,1.36E-01
regulation of trans-synaptic signaling (GO:0099177),21,1,3.86,-,0.26,1.02E-01
modulation of chemical synaptic transmission (GO:0050804),21,1,3.86,-,0.26,1.02E-01
positive regulation of catabolic process (GO:0009896),21,1,3.86,-,0.26,1.02E-01
negative regulation of nucleic acid-templated transcription (GO:1903507),69,3,12.68,-,0.24,1.29E-03
"negative regulation of transcription, DNA-templated (GO:0045892)",69,3,12.68,-,0.24,1.29E-03
negative regulation of RNA biosynthetic process (GO:1902679),69,3,12.68,-,0.24,1.29E-03
negative regulation of RNA metabolic process (GO:0051253),70,3,12.86,-,0.23,1.12E-03
negative regulation of nucleobase-containing compound metabolic process (GO:0045934),71,3,13.05,-,0.23,9.65E-04
intermediate filament cytoskeleton organization (GO:0045104),1,0,0.18,-, < 0.01,8.32E-01
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),1,0,0.18,-, < 0.01,8.32E-01
regulation of neurotransmitter receptor activity (GO:0099601),2,0,0.37,-, < 0.01,6.92E-01
regulation of lipid biosynthetic process (GO:0046890),2,0,0.37,-, < 0.01,6.92E-01
regulation of hormone secretion (GO:0046883),1,0,0.18,-, < 0.01,8.32E-01
purine ribonucleoside monophosphate metabolic process (GO:0009167),6,0,1.1,-, < 0.01,3.32E-01
nucleotide catabolic process (GO:0009166),3,0,0.55,-, < 0.01,5.76E-01
ribonucleoside monophosphate metabolic process (GO:0009161),7,0,1.29,-, < 0.01,2.76E-01
regulation of AMPA receptor activity (GO:2000311),1,0,0.18,-, < 0.01,8.32E-01
hormone secretion (GO:0046879),1,0,0.18,-, < 0.01,8.32E-01
striated muscle cell differentiation (GO:0051146),2,0,0.37,-, < 0.01,6.92E-01
purine ribonucleotide catabolic process (GO:0009154),1,0,0.18,-, < 0.01,8.32E-01
positive regulation of cell adhesion (GO:0045785),2,0,0.37,-, < 0.01,6.92E-01
regulation of lipid metabolic process (GO:0019216),3,0,0.55,-, < 0.01,5.76E-01
glycerolipid catabolic process (GO:0046503),3,0,0.55,-, < 0.01,5.76E-01
nucleoside triphosphate catabolic process (GO:0009143),2,0,0.37,-, < 0.01,6.92E-01
regulation of stress fiber assembly (GO:0051492),1,0,0.18,-, < 0.01,8.32E-01
mitochondrial fusion (GO:0008053),1,0,0.18,-, < 0.01,8.32E-01
regulation of chromatin assembly or disassembly (GO:0001672),2,0,0.37,-, < 0.01,6.92E-01
purine nucleoside monophosphate metabolic process (GO:0009126),6,0,1.1,-, < 0.01,3.32E-01
response to hypoxia (GO:0001666),2,0,0.37,-, < 0.01,6.92E-01
nucleoside monophosphate metabolic process (GO:0009123),9,0,1.65,-, < 0.01,1.91E-01
hippo signaling (GO:0035329),3,0,0.55,-, < 0.01,5.76E-01
urogenital system development (GO:0001655),1,0,0.18,-, < 0.01,8.32E-01
calcium ion import (GO:0070509),5,0,0.92,-, < 0.01,3.99E-01
negative regulation of Notch signaling pathway (GO:0045746),2,0,0.37,-, < 0.01,6.92E-01
positive regulation of DNA repair (GO:0045739),1,0,0.18,-, < 0.01,8.32E-01
intracellular pH reduction (GO:0051452),7,0,1.29,-, < 0.01,2.76E-01
blood circulation (GO:0008015),1,0,0.18,-, < 0.01,8.32E-01
negative regulation of protein dephosphorylation (GO:0035308),2,0,0.37,-, < 0.01,6.92E-01
spermatid development (GO:0007286),1,0,0.18,-, < 0.01,8.32E-01
negative regulation of dephosphorylation (GO:0035305),3,0,0.55,-, < 0.01,5.76E-01
regulation of protein dephosphorylation (GO:0035304),4,0,0.74,-, < 0.01,4.79E-01
spermatogenesis (GO:0007283),2,0,0.37,-, < 0.01,6.92E-01
positive regulation of neuron projection development (GO:0010976),3,0,0.55,-, < 0.01,5.76E-01
regulation of neuron projection development (GO:0010975),5,0,0.92,-, < 0.01,3.99E-01
response to growth factor (GO:0070848),16,0,2.94,-, < 0.01,5.26E-02
neuromuscular synaptic transmission (GO:0007274),2,0,0.37,-, < 0.01,6.92E-01
"synaptic transmission, cholinergic (GO:0007271)",2,0,0.37,-, < 0.01,6.92E-01
negative regulation of canonical Wnt signaling pathway (GO:0090090),5,0,0.92,-, < 0.01,3.99E-01
lipid translocation (GO:0034204),4,0,0.74,-, < 0.01,4.79E-01
response to organic cyclic compound (GO:0014070),4,0,0.74,-, < 0.01,4.79E-01
negative regulation of macroautophagy (GO:0016242),1,0,0.18,-, < 0.01,8.32E-01
regulation of macroautophagy (GO:0016241),6,0,1.1,-, < 0.01,3.32E-01
calcium ion transport into cytosol (GO:0060402),5,0,0.92,-, < 0.01,3.99E-01
cytosolic calcium ion transport (GO:0060401),6,0,1.1,-, < 0.01,3.32E-01
positive regulation of peptidase activity (GO:0010952),2,0,0.37,-, < 0.01,6.92E-01
positive regulation of endopeptidase activity (GO:0010950),2,0,0.37,-, < 0.01,6.92E-01
heterochromatin organization (GO:0070828),2,0,0.37,-, < 0.01,6.92E-01
mitochondrial respiratory chain complex II assembly (GO:0034553),1,0,0.18,-, < 0.01,8.32E-01
positive regulation of cell division (GO:0051781),1,0,0.18,-, < 0.01,8.32E-01
post-embryonic development (GO:0009791),1,0,0.18,-, < 0.01,8.32E-01
phosphatidylinositol 3-kinase signaling (GO:0014065),2,0,0.37,-, < 0.01,6.92E-01
lysosomal microautophagy (GO:0016237),4,0,0.74,-, < 0.01,4.79E-01
endosome to lysosome transport (GO:0008333),1,0,0.18,-, < 0.01,8.32E-01
extracellular matrix organization (GO:0030198),10,0,1.84,-, < 0.01,1.59E-01
nucleolar large rRNA transcription by RNA polymerase I (GO:0042790),1,0,0.18,-, < 0.01,8.32E-01
positive regulation of cell cycle process (GO:0090068),8,0,1.47,-, < 0.01,2.30E-01
response to UV (GO:0009411),3,0,0.55,-, < 0.01,5.76E-01
histone deubiquitination (GO:0016578),3,0,0.55,-, < 0.01,5.76E-01
epithelial cell proliferation (GO:0050673),1,0,0.18,-, < 0.01,8.32E-01
histone deacetylation (GO:0016575),6,0,1.1,-, < 0.01,3.32E-01
cellular component assembly involved in morphogenesis (GO:0010927),2,0,0.37,-, < 0.01,6.92E-01
response to cold (GO:0009409),2,0,0.37,-, < 0.01,6.92E-01
response to heat (GO:0009408),2,0,0.37,-, < 0.01,6.92E-01
negative regulation of phosphatase activity (GO:0010923),2,0,0.37,-, < 0.01,6.92E-01
regulation of phosphatase activity (GO:0010921),3,0,0.55,-, < 0.01,5.76E-01
signal transduction in response to DNA damage (GO:0042770),2,0,0.37,-, < 0.01,6.92E-01
smoothened signaling pathway (GO:0007224),1,0,0.18,-, < 0.01,8.32E-01
protein deacylation (GO:0035601),7,0,1.29,-, < 0.01,2.76E-01
hormone-mediated signaling pathway (GO:0009755),8,0,1.47,-, < 0.01,2.30E-01
cristae formation (GO:0042407),2,0,0.37,-, < 0.01,6.92E-01
dopamine receptor signaling pathway (GO:0007212),2,0,0.37,-, < 0.01,6.92E-01
"mitochondrial electron transport, succinate to ubiquinone (GO:0006121)",1,0,0.18,-, < 0.01,8.32E-01
protein demethylation (GO:0006482),2,0,0.37,-, < 0.01,6.92E-01
regulation of cell adhesion (GO:0030155),5,0,0.92,-, < 0.01,3.99E-01
positive regulation of cytosolic calcium ion concentration (GO:0007204),5,0,0.92,-, < 0.01,3.99E-01
protein deacetylation (GO:0006476),6,0,1.1,-, < 0.01,3.32E-01
N-terminal protein amino acid acetylation (GO:0006474),2,0,0.37,-, < 0.01,6.92E-01
sphingolipid catabolic process (GO:0030149),1,0,0.18,-, < 0.01,8.32E-01
defense response to bacterium (GO:0042742),3,0,0.55,-, < 0.01,5.76E-01
carbohydrate transport (GO:0008643),1,0,0.18,-, < 0.01,8.32E-01
apoptotic mitochondrial changes (GO:0008637),1,0,0.18,-, < 0.01,8.32E-01
detection of mechanical stimulus (GO:0050982),3,0,0.55,-, < 0.01,5.76E-01
sex differentiation (GO:0007548),3,0,0.55,-, < 0.01,5.76E-01
inositol phosphate-mediated signaling (GO:0048016),2,0,0.37,-, < 0.01,6.92E-01
G2 DNA damage checkpoint (GO:0031572),4,0,0.74,-, < 0.01,4.79E-01
organelle transport along microtubule (GO:0072384),4,0,0.74,-, < 0.01,4.79E-01
muscle organ development (GO:0007517),1,0,0.18,-, < 0.01,8.32E-01
positive regulation of cysteine-type endopeptidase activity (GO:2001056),1,0,0.18,-, < 0.01,8.32E-01
dendritic spine organization (GO:0097061),1,0,0.18,-, < 0.01,8.32E-01
translational termination (GO:0006415),1,0,0.18,-, < 0.01,8.32E-01
chromosome organization involved in meiotic cell cycle (GO:0070192),8,0,1.47,-, < 0.01,2.30E-01
folic acid-containing compound metabolic process (GO:0006760),5,0,0.92,-, < 0.01,3.99E-01
positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),6,0,1.1,-, < 0.01,3.32E-01
axon extension (GO:0048675),1,0,0.18,-, < 0.01,8.32E-01
positive regulation of response to DNA damage stimulus (GO:2001022),2,0,0.37,-, < 0.01,6.92E-01
mitochondrion distribution (GO:0048311),1,0,0.18,-, < 0.01,8.32E-01
regulation of membrane lipid distribution (GO:0097035),4,0,0.74,-, < 0.01,4.79E-01
"chemical synaptic transmission, postsynaptic (GO:0099565)",1,0,0.18,-, < 0.01,8.32E-01
heterochromatin assembly (GO:0031507),2,0,0.37,-, < 0.01,6.92E-01
ubiquinone biosynthetic process (GO:0006744),2,0,0.37,-, < 0.01,6.92E-01
monocarboxylic acid transport (GO:0015718),3,0,0.55,-, < 0.01,5.76E-01
phosphatidylcholine metabolic process (GO:0046470),1,0,0.18,-, < 0.01,8.32E-01
acylglycerol catabolic process (GO:0046464),3,0,0.55,-, < 0.01,5.76E-01
neutral lipid catabolic process (GO:0046461),3,0,0.55,-, < 0.01,5.76E-01
activin receptor signaling pathway (GO:0032924),1,0,0.18,-, < 0.01,8.32E-01
morphogenesis of an epithelium (GO:0002009),5,0,0.92,-, < 0.01,3.99E-01
autophagosome maturation (GO:0097352),2,0,0.37,-, < 0.01,6.92E-01
TORC1 signaling (GO:0038202),6,0,1.1,-, < 0.01,3.32E-01
cellular response to misfolded protein (GO:0071218),3,0,0.55,-, < 0.01,5.76E-01
positive regulation of cell cycle G1/S phase transition (GO:1902808),2,0,0.37,-, < 0.01,6.92E-01
regulation of cell cycle G1/S phase transition (GO:1902806),5,0,0.92,-, < 0.01,3.99E-01
response to oxygen levels (GO:0070482),2,0,0.37,-, < 0.01,6.92E-01
vesicle cytoskeletal trafficking (GO:0099518),14,0,2.57,-, < 0.01,7.61E-02
tube development (GO:0035295),3,0,0.55,-, < 0.01,5.76E-01
cellular response to transforming growth factor beta stimulus (GO:0071560),4,0,0.74,-, < 0.01,4.79E-01
heart contraction (GO:0060047),1,0,0.18,-, < 0.01,8.32E-01
synaptic vesicle cycle (GO:0099504),13,0,2.39,-, < 0.01,9.15E-02
response to transforming growth factor beta (GO:0071559),4,0,0.74,-, < 0.01,4.79E-01
reproductive structure development (GO:0048608),1,0,0.18,-, < 0.01,8.32E-01
negative regulation of small GTPase mediated signal transduction (GO:0051058),1,0,0.18,-, < 0.01,8.32E-01
negative regulation of DNA metabolic process (GO:0051053),2,0,0.37,-, < 0.01,6.92E-01
phospholipid translocation (GO:0045332),4,0,0.74,-, < 0.01,4.79E-01
protein mannosylation (GO:0035268),1,0,0.18,-, < 0.01,8.32E-01
response to ionizing radiation (GO:0010212),5,0,0.92,-, < 0.01,3.99E-01
positive regulation of secretion (GO:0051047),1,0,0.18,-, < 0.01,8.32E-01
gliogenesis (GO:0042063),2,0,0.37,-, < 0.01,6.92E-01
wound healing (GO:0042060),1,0,0.18,-, < 0.01,8.32E-01
protein localization to lysosome (GO:0061462),3,0,0.55,-, < 0.01,5.76E-01
stress fiber assembly (GO:0043149),1,0,0.18,-, < 0.01,8.32E-01
neuron projection extension (GO:1990138),1,0,0.18,-, < 0.01,8.32E-01
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),2,0,0.37,-, < 0.01,6.92E-01
reproductive system development (GO:0061458),1,0,0.18,-, < 0.01,8.32E-01
establishment of mitotic spindle orientation (GO:0000132),3,0,0.55,-, < 0.01,5.76E-01
folic acid-containing compound biosynthetic process (GO:0009396),1,0,0.18,-, < 0.01,8.32E-01
phospholipid catabolic process (GO:0009395),1,0,0.18,-, < 0.01,8.32E-01
positive regulation of neuron differentiation (GO:0045666),3,0,0.55,-, < 0.01,5.76E-01
macromolecule deacylation (GO:0098732),7,0,1.29,-, < 0.01,2.76E-01
regulation of neuron differentiation (GO:0045664),6,0,1.1,-, < 0.01,3.32E-01
tube morphogenesis (GO:0035239),3,0,0.55,-, < 0.01,5.76E-01
ionotropic glutamate receptor signaling pathway (GO:0035235),1,0,0.18,-, < 0.01,8.32E-01
regulation of mRNA stability (GO:0043488),3,0,0.55,-, < 0.01,5.76E-01
regulation of RNA stability (GO:0043487),3,0,0.55,-, < 0.01,5.76E-01
"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",2,0,0.37,-, < 0.01,6.92E-01
intracellular mRNA localization (GO:0008298),3,0,0.55,-, < 0.01,5.76E-01
endonucleolytic cleavage involved in rRNA processing (GO:0000478),2,0,0.37,-, < 0.01,6.92E-01
snRNA processing (GO:0016180),12,0,2.21,-, < 0.01,1.10E-01
pigmentation (GO:0043473),2,0,0.37,-, < 0.01,6.92E-01
regulation of cell growth (GO:0001558),2,0,0.37,-, < 0.01,6.92E-01
"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",4,0,0.74,-, < 0.01,4.79E-01
negative regulation of cell population proliferation (GO:0008285),2,0,0.37,-, < 0.01,6.92E-01
positive regulation of cell population proliferation (GO:0008284),5,0,0.92,-, < 0.01,3.99E-01
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),5,0,0.92,-, < 0.01,3.99E-01
non-canonical Wnt signaling pathway (GO:0035567),6,0,1.1,-, < 0.01,3.32E-01
head development (GO:0060322),1,0,0.18,-, < 0.01,8.32E-01
cilium or flagellum-dependent cell motility (GO:0001539),2,0,0.37,-, < 0.01,6.92E-01
snRNA 3'-end processing (GO:0034472),12,0,2.21,-, < 0.01,1.10E-01
"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",1,0,0.18,-, < 0.01,8.32E-01
transforming growth factor beta receptor signaling pathway (GO:0007179),4,0,0.74,-, < 0.01,4.79E-01
positive regulation of autophagy (GO:0010508),4,0,0.74,-, < 0.01,4.79E-01
negative regulation of autophagy (GO:0010507),1,0,0.18,-, < 0.01,8.32E-01
epidermal growth factor receptor signaling pathway (GO:0007173),2,0,0.37,-, < 0.01,6.92E-01
regulation of autophagosome maturation (GO:1901096),1,0,0.18,-, < 0.01,8.32E-01
negative regulation of cell adhesion (GO:0007162),1,0,0.18,-, < 0.01,8.32E-01
negative regulation of DNA-binding transcription factor activity (GO:0043433),1,0,0.18,-, < 0.01,8.32E-01
microtubule anchoring (GO:0034453),2,0,0.37,-, < 0.01,6.92E-01
regulation of chromatin assembly (GO:0010847),1,0,0.18,-, < 0.01,8.32E-01
action potential (GO:0001508),3,0,0.55,-, < 0.01,5.76E-01
muscle cell differentiation (GO:0042692),2,0,0.37,-, < 0.01,6.92E-01
sterol biosynthetic process (GO:0016126),1,0,0.18,-, < 0.01,8.32E-01
sterol metabolic process (GO:0016125),1,0,0.18,-, < 0.01,8.32E-01
male meiotic nuclear division (GO:0007140),1,0,0.18,-, < 0.01,8.32E-01
telomere maintenance via telomere lengthening (GO:0010833),2,0,0.37,-, < 0.01,6.92E-01
regulation of cell division (GO:0051302),4,0,0.74,-, < 0.01,4.79E-01
oligosaccharide biosynthetic process (GO:0009312),1,0,0.18,-, < 0.01,8.32E-01
positive regulation of translational initiation (GO:0045948),1,0,0.18,-, < 0.01,8.32E-01
antibacterial humoral response (GO:0019731),3,0,0.55,-, < 0.01,5.76E-01
antimicrobial humoral response (GO:0019730),3,0,0.55,-, < 0.01,5.76E-01
regulation of dendritic spine development (GO:0060998),1,0,0.18,-, < 0.01,8.32E-01
steroid hormone mediated signaling pathway (GO:0043401),1,0,0.18,-, < 0.01,8.32E-01
positive regulation of mitotic cell cycle (GO:0045931),7,0,1.29,-, < 0.01,2.76E-01
homologous chromosome pairing at meiosis (GO:0007129),2,0,0.37,-, < 0.01,6.92E-01
calcium-mediated signaling (GO:0019722),5,0,0.92,-, < 0.01,3.99E-01
cell cycle G1/S phase transition (GO:0044843),9,0,1.65,-, < 0.01,1.91E-01
nucleus localization (GO:0051647),3,0,0.55,-, < 0.01,5.76E-01
positive regulation of cell-substrate adhesion (GO:0010811),1,0,0.18,-, < 0.01,8.32E-01
positive regulation of growth (GO:0045927),2,0,0.37,-, < 0.01,6.92E-01
centrosome localization (GO:0051642),3,0,0.55,-, < 0.01,5.76E-01
mitochondrial transcription (GO:0006390),4,0,0.74,-, < 0.01,4.79E-01
positive regulation of exocytosis (GO:0045921),1,0,0.18,-, < 0.01,8.32E-01
steroid metabolic process (GO:0008202),1,0,0.18,-, < 0.01,8.32E-01
actomyosin contractile ring organization (GO:0044837),1,0,0.18,-, < 0.01,8.32E-01
"nucleotide-excision repair, DNA incision (GO:0033683)",4,0,0.74,-, < 0.01,4.79E-01
"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",1,0,0.18,-, < 0.01,8.32E-01
aminoglycan metabolic process (GO:0006022),10,0,1.84,-, < 0.01,1.59E-01
transcription by RNA polymerase III (GO:0006383),5,0,0.92,-, < 0.01,3.99E-01
negative regulation of DNA recombination (GO:0045910),2,0,0.37,-, < 0.01,6.92E-01
"DNA catabolic process, endonucleolytic (GO:0000737)",7,0,1.29,-, < 0.01,2.76E-01
DNA synthesis involved in DNA repair (GO:0000731),3,0,0.55,-, < 0.01,5.76E-01
regulation of gene silencing (GO:0060968),4,0,0.74,-, < 0.01,4.79E-01
chloride transmembrane transport (GO:1902476),4,0,0.74,-, < 0.01,4.79E-01
negative regulation of cellular response to growth factor stimulus (GO:0090288),3,0,0.55,-, < 0.01,5.76E-01
regulation of cellular response to growth factor stimulus (GO:0090287),5,0,0.92,-, < 0.01,3.99E-01
response to toxic substance (GO:0009636),3,0,0.55,-, < 0.01,5.76E-01
iron ion transmembrane transport (GO:0034755),1,0,0.18,-, < 0.01,8.32E-01
non-recombinational repair (GO:0000726),4,0,0.74,-, < 0.01,4.79E-01
epidermis development (GO:0008544),1,0,0.18,-, < 0.01,8.32E-01
fibroblast growth factor receptor signaling pathway (GO:0008543),3,0,0.55,-, < 0.01,5.76E-01
contractile actin filament bundle assembly (GO:0030038),1,0,0.18,-, < 0.01,8.32E-01
response to mechanical stimulus (GO:0009612),3,0,0.55,-, < 0.01,5.76E-01
response to wounding (GO:0009611),1,0,0.18,-, < 0.01,8.32E-01
positive regulation of nervous system development (GO:0051962),3,0,0.55,-, < 0.01,5.76E-01
positive regulation of secretion by cell (GO:1903532),1,0,0.18,-, < 0.01,8.32E-01
copper ion homeostasis (GO:0055070),1,0,0.18,-, < 0.01,8.32E-01
chromatin silencing at telomere (GO:0006348),3,0,0.55,-, < 0.01,5.76E-01
piecemeal microautophagy of the nucleus (GO:0034727),4,0,0.74,-, < 0.01,4.79E-01
septin ring organization (GO:0031106),1,0,0.18,-, < 0.01,8.32E-01
DNA replication-independent nucleosome organization (GO:0034724),4,0,0.74,-, < 0.01,4.79E-01
chromatin silencing (GO:0006342),10,0,1.84,-, < 0.01,1.59E-01
regulation of receptor-mediated endocytosis (GO:0048259),3,0,0.55,-, < 0.01,5.76E-01
brain development (GO:0007420),1,0,0.18,-, < 0.01,8.32E-01
steroid biosynthetic process (GO:0006694),1,0,0.18,-, < 0.01,8.32E-01
sperm capacitation (GO:0048240),1,0,0.18,-, < 0.01,8.32E-01
positive regulation of calcium ion transport (GO:0051928),2,0,0.37,-, < 0.01,6.92E-01
male gamete generation (GO:0048232),2,0,0.37,-, < 0.01,6.92E-01
regulation of calcium ion transport (GO:0051924),4,0,0.74,-, < 0.01,4.79E-01
mitotic recombination (GO:0006312),5,0,0.92,-, < 0.01,3.99E-01
defense response to Gram-positive bacterium (GO:0050830),3,0,0.55,-, < 0.01,5.76E-01
developmental growth (GO:0048589),3,0,0.55,-, < 0.01,5.76E-01
developmental cell growth (GO:0048588),1,0,0.18,-, < 0.01,8.32E-01
DNA catabolic process (GO:0006308),7,0,1.29,-, < 0.01,2.76E-01
nucleotide transmembrane transport (GO:1901679),1,0,0.18,-, < 0.01,8.32E-01
double-strand break repair via nonhomologous end joining (GO:0006303),4,0,0.74,-, < 0.01,4.79E-01
vesicle transport along microtubule (GO:0047496),4,0,0.74,-, < 0.01,4.79E-01
defense response to Gram-negative bacterium (GO:0050829),3,0,0.55,-, < 0.01,5.76E-01
protein stabilization (GO:0050821),4,0,0.74,-, < 0.01,4.79E-01
regulation of cell migration (GO:0030334),2,0,0.37,-, < 0.01,6.92E-01
IMP metabolic process (GO:0046040),2,0,0.37,-, < 0.01,6.92E-01
hormone transport (GO:0009914),1,0,0.18,-, < 0.01,8.32E-01
epidermal cell differentiation (GO:0009913),1,0,0.18,-, < 0.01,8.32E-01
AMP metabolic process (GO:0046033),5,0,0.92,-, < 0.01,3.99E-01
embryonic organ development (GO:0048568),1,0,0.18,-, < 0.01,8.32E-01
regulation of synapse organization (GO:0050807),1,0,0.18,-, < 0.01,8.32E-01
positive regulation of synaptic transmission (GO:0050806),2,0,0.37,-, < 0.01,6.92E-01
regulation of synapse structure or activity (GO:0050803),2,0,0.37,-, < 0.01,6.92E-01
striated muscle cell development (GO:0055002),2,0,0.37,-, < 0.01,6.92E-01
muscle cell development (GO:0055001),2,0,0.37,-, < 0.01,6.92E-01
heart process (GO:0003015),1,0,0.18,-, < 0.01,8.32E-01
circulatory system process (GO:0003013),1,0,0.18,-, < 0.01,8.32E-01
muscle system process (GO:0003012),3,0,0.55,-, < 0.01,5.76E-01
ERBB signaling pathway (GO:0038127),2,0,0.37,-, < 0.01,6.92E-01
positive regulation of cell growth (GO:0030307),2,0,0.37,-, < 0.01,6.92E-01
clathrin-dependent endocytosis (GO:0072583),6,0,1.1,-, < 0.01,3.32E-01
response to steroid hormone (GO:0048545),1,0,0.18,-, < 0.01,8.32E-01
skeletal muscle contraction (GO:0003009),1,0,0.18,-, < 0.01,8.32E-01
protein targeting to lysosome (GO:0006622),2,0,0.37,-, < 0.01,6.92E-01
positive regulation of cell-cell adhesion (GO:0022409),1,0,0.18,-, < 0.01,8.32E-01
regulation of cell-cell adhesion (GO:0022407),1,0,0.18,-, < 0.01,8.32E-01
interstrand cross-link repair (GO:0036297),5,0,0.92,-, < 0.01,3.99E-01
response to decreased oxygen levels (GO:0036293),2,0,0.37,-, < 0.01,6.92E-01
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1,0,0.18,-, < 0.01,8.32E-01
regulation of extrinsic apoptotic signaling pathway (GO:2001236),1,0,0.18,-, < 0.01,8.32E-01
negative regulation of apoptotic signaling pathway (GO:2001234),1,0,0.18,-, < 0.01,8.32E-01
regulation of apoptotic signaling pathway (GO:2001233),1,0,0.18,-, < 0.01,8.32E-01
positive regulation of cell motility (GO:2000147),1,0,0.18,-, < 0.01,8.32E-01
regulation of cell motility (GO:2000145),3,0,0.55,-, < 0.01,5.76E-01
G1/S transition of mitotic cell cycle (GO:0000082),9,0,1.65,-, < 0.01,1.91E-01
amino sugar catabolic process (GO:0046348),11,0,2.02,-, < 0.01,1.32E-01
spermatid differentiation (GO:0048515),1,0,0.18,-, < 0.01,8.32E-01
"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",7,0,1.29,-, < 0.01,2.76E-01
humoral immune response (GO:0006959),3,0,0.55,-, < 0.01,5.76E-01
inflammatory response (GO:0006954),3,0,0.55,-, < 0.01,5.76E-01
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),2,0,0.37,-, < 0.01,6.92E-01
striated muscle contraction (GO:0006941),1,0,0.18,-, < 0.01,8.32E-01
cilium movement involved in cell motility (GO:0060294),2,0,0.37,-, < 0.01,6.92E-01
extracellular structure organization (GO:0043062),10,0,1.84,-, < 0.01,1.59E-01
sterol transport (GO:0015918),6,0,1.1,-, < 0.01,3.32E-01
positive regulation of cell differentiation (GO:0045597),5,0,0.92,-, < 0.01,3.99E-01
muscle contraction (GO:0006936),3,0,0.55,-, < 0.01,5.76E-01
regulation of mRNA catabolic process (GO:0061013),4,0,0.74,-, < 0.01,4.79E-01
toll-like receptor signaling pathway (GO:0002224),1,0,0.18,-, < 0.01,8.32E-01
pattern recognition receptor signaling pathway (GO:0002221),1,0,0.18,-, < 0.01,8.32E-01
cilium-dependent cell motility (GO:0060285),2,0,0.37,-, < 0.01,6.92E-01
long-chain fatty acid transport (GO:0015909),1,0,0.18,-, < 0.01,8.32E-01
regulation of signaling receptor activity (GO:0010469),2,0,0.37,-, < 0.01,6.92E-01
protein localization to Golgi apparatus (GO:0034067),3,0,0.55,-, < 0.01,5.76E-01
cell-cell junction organization (GO:0045216),4,0,0.74,-, < 0.01,4.79E-01
sarcomere organization (GO:0045214),1,0,0.18,-, < 0.01,8.32E-01
calcium ion transmembrane import into cytosol (GO:0097553),5,0,0.92,-, < 0.01,3.99E-01
protein N-linked glycosylation via asparagine (GO:0018279),3,0,0.55,-, < 0.01,5.76E-01
cellular response to BMP stimulus (GO:0071773),11,0,2.02,-, < 0.01,1.32E-01
response to BMP (GO:0071772),11,0,2.02,-, < 0.01,1.32E-01
negative regulation of sequestering of calcium ion (GO:0051283),2,0,0.37,-, < 0.01,6.92E-01
regulation of sequestering of calcium ion (GO:0051282),2,0,0.37,-, < 0.01,6.92E-01
chromatin organization involved in negative regulation of transcription (GO:0097549),12,0,2.21,-, < 0.01,1.10E-01
spliceosomal snRNP assembly (GO:0000387),8,0,1.47,-, < 0.01,2.30E-01
cellular response to organic cyclic compound (GO:0071407),4,0,0.74,-, < 0.01,4.79E-01
positive regulation of cellular component movement (GO:0051272),1,0,0.18,-, < 0.01,8.32E-01
regulation of dendrite morphogenesis (GO:0048814),2,0,0.37,-, < 0.01,6.92E-01
regulation of cellular component movement (GO:0051270),3,0,0.55,-, < 0.01,5.76E-01
dendrite morphogenesis (GO:0048813),2,0,0.37,-, < 0.01,6.92E-01
regulation of DNA recombination (GO:0000018),3,0,0.55,-, < 0.01,5.76E-01
protein localization to cell surface (GO:0034394),2,0,0.37,-, < 0.01,6.92E-01
synaptic vesicle exocytosis (GO:0016079),6,0,1.1,-, < 0.01,3.32E-01
regulation of autophagosome assembly (GO:2000785),2,0,0.37,-, < 0.01,6.92E-01
nuclear migration (GO:0007097),3,0,0.55,-, < 0.01,5.76E-01
regulation of exit from mitosis (GO:0007096),1,0,0.18,-, < 0.01,8.32E-01
mitotic G2 DNA damage checkpoint (GO:0007095),4,0,0.74,-, < 0.01,4.79E-01
response to temperature stimulus (GO:0009266),4,0,0.74,-, < 0.01,4.79E-01
negative regulation of multicellular organismal process (GO:0051241),1,0,0.18,-, < 0.01,8.32E-01
positive regulation of multicellular organismal process (GO:0051240),3,0,0.55,-, < 0.01,5.76E-01
mannosylation (GO:0097502),1,0,0.18,-, < 0.01,8.32E-01
mitotic chromosome condensation (GO:0007076),7,0,1.29,-, < 0.01,2.76E-01
regulation of cell morphogenesis involved in differentiation (GO:0010769),6,0,1.1,-, < 0.01,3.32E-01
transposition (GO:0032196),4,0,0.74,-, < 0.01,4.79E-01
neuron death (GO:0070997),1,0,0.18,-, < 0.01,8.32E-01
cell growth (GO:0016049),2,0,0.37,-, < 0.01,6.92E-01
cell cycle DNA replication (GO:0044786),11,0,2.02,-, < 0.01,1.32E-01
peptidyl-arginine methylation (GO:0018216),1,0,0.18,-, < 0.01,8.32E-01
mitotic sister chromatid cohesion (GO:0007064),3,0,0.55,-, < 0.01,5.76E-01
sister chromatid cohesion (GO:0007062),9,0,1.65,-, < 0.01,1.91E-01
septin cytoskeleton organization (GO:0032185),1,0,0.18,-, < 0.01,8.32E-01
developmental growth involved in morphogenesis (GO:0060560),3,0,0.55,-, < 0.01,5.76E-01
oxidative demethylation (GO:0070989),1,0,0.18,-, < 0.01,8.32E-01
demethylation (GO:0070988),3,0,0.55,-, < 0.01,5.76E-01
plasma membrane phospholipid scrambling (GO:0017121),3,0,0.55,-, < 0.01,5.76E-01
nuclear DNA replication (GO:0033260),11,0,2.02,-, < 0.01,1.32E-01
telomere-telomerase complex assembly (GO:1905324),2,0,0.37,-, < 0.01,6.92E-01
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),4,0,0.74,-, < 0.01,4.79E-01
cell cycle arrest (GO:0007050),1,0,0.18,-, < 0.01,8.32E-01
pH reduction (GO:0045851),7,0,1.29,-, < 0.01,2.76E-01
glucose homeostasis (GO:0042593),1,0,0.18,-, < 0.01,8.32E-01
cell-substrate junction assembly (GO:0007044),1,0,0.18,-, < 0.01,8.32E-01
cell-cell junction assembly (GO:0007043),2,0,0.37,-, < 0.01,6.92E-01
lysosomal transport (GO:0007041),4,0,0.74,-, < 0.01,4.79E-01
lysosome organization (GO:0007040),1,0,0.18,-, < 0.01,8.32E-01
release of sequestered calcium ion into cytosol (GO:0051209),2,0,0.37,-, < 0.01,6.92E-01
sequestering of calcium ion (GO:0051208),2,0,0.37,-, < 0.01,6.92E-01
mitochondrial calcium ion homeostasis (GO:0051560),1,0,0.18,-, < 0.01,8.32E-01
positive regulation of mitotic nuclear division (GO:0045840),3,0,0.55,-, < 0.01,5.76E-01
vacuolar acidification (GO:0007035),7,0,1.29,-, < 0.01,2.76E-01
skeletal muscle organ development (GO:0060538),1,0,0.18,-, < 0.01,8.32E-01
regulation of neurotransmitter secretion (GO:0046928),1,0,0.18,-, < 0.01,8.32E-01
muscle tissue development (GO:0060537),1,0,0.18,-, < 0.01,8.32E-01
endosome organization (GO:0007032),4,0,0.74,-, < 0.01,4.79E-01
regulation of phosphoprotein phosphatase activity (GO:0043666),2,0,0.37,-, < 0.01,6.92E-01
positive regulation of cell development (GO:0010720),4,0,0.74,-, < 0.01,4.79E-01
translesion synthesis (GO:0019985),3,0,0.55,-, < 0.01,5.76E-01
endoplasmic reticulum organization (GO:0007029),9,0,1.65,-, < 0.01,1.91E-01
establishment of planar polarity (GO:0001736),3,0,0.55,-, < 0.01,5.76E-01
base-excision repair (GO:0006284),5,0,0.92,-, < 0.01,3.99E-01
"negative regulation of gene expression, epigenetic (GO:0045814)",10,0,1.84,-, < 0.01,1.59E-01
nucleoside phosphate catabolic process (GO:1901292),3,0,0.55,-, < 0.01,5.76E-01
telomere maintenance via telomerase (GO:0007004),2,0,0.37,-, < 0.01,6.92E-01
positive regulation of locomotion (GO:0040017),1,0,0.18,-, < 0.01,8.32E-01
regulation of locomotion (GO:0040012),3,0,0.55,-, < 0.01,5.76E-01
DNA strand elongation involved in DNA replication (GO:0006271),9,0,1.65,-, < 0.01,1.91E-01
regulation of plasma membrane bounded cell projection organization (GO:0120035),5,0,0.92,-, < 0.01,3.99E-01
regulation of growth (GO:0040008),2,0,0.37,-, < 0.01,6.92E-01
growth (GO:0040007),4,0,0.74,-, < 0.01,4.79E-01
establishment of mitotic spindle localization (GO:0040001),4,0,0.74,-, < 0.01,4.79E-01
pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),6,0,1.1,-, < 0.01,3.32E-01
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),6,0,1.1,-, < 0.01,3.32E-01
positive regulation of cytokinesis (GO:0032467),1,0,0.18,-, < 0.01,8.32E-01
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1,0,0.18,-, < 0.01,8.32E-01
regulation of cytokinesis (GO:0032465),3,0,0.55,-, < 0.01,5.76E-01
intraciliary retrograde transport (GO:0035721),4,0,0.74,-, < 0.01,4.79E-01
regulation of dendrite development (GO:0050773),2,0,0.37,-, < 0.01,6.92E-01
cGMP-mediated signaling (GO:0019934),2,0,0.37,-, < 0.01,6.92E-01
positive regulation of axonogenesis (GO:0050772),3,0,0.55,-, < 0.01,5.76E-01
regulation of axonogenesis (GO:0050770),4,0,0.74,-, < 0.01,4.79E-01
regulation of synaptic plasticity (GO:0048167),1,0,0.18,-, < 0.01,8.32E-01
histone H3 acetylation (GO:0043966),7,0,1.29,-, < 0.01,2.76E-01
positive regulation of neurogenesis (GO:0050769),3,0,0.55,-, < 0.01,5.76E-01
mitochondrial RNA metabolic process (GO:0000959),5,0,0.92,-, < 0.01,3.99E-01
negative regulation of cAMP-mediated signaling (GO:0043951),5,0,0.92,-, < 0.01,3.99E-01
lipid storage (GO:0019915),2,0,0.37,-, < 0.01,6.92E-01
chromosome condensation (GO:0030261),10,0,1.84,-, < 0.01,1.59E-01
melanosome organization (GO:0032438),1,0,0.18,-, < 0.01,8.32E-01
cellular response to heat (GO:0034605),2,0,0.37,-, < 0.01,6.92E-01
positive regulation of cell projection organization (GO:0031346),3,0,0.55,-, < 0.01,5.76E-01
catecholamine metabolic process (GO:0006584),3,0,0.55,-, < 0.01,5.76E-01
regulation of cell projection organization (GO:0031344),5,0,0.92,-, < 0.01,3.99E-01
tyrosine metabolic process (GO:0006570),1,0,0.18,-, < 0.01,8.32E-01
NIK/NF-kappaB signaling (GO:0038061),2,0,0.37,-, < 0.01,6.92E-01
synaptic vesicle endocytosis (GO:0048488),6,0,1.1,-, < 0.01,3.32E-01
negative regulation of neuron death (GO:1901215),1,0,0.18,-, < 0.01,8.32E-01
regulation of neuron death (GO:1901214),1,0,0.18,-, < 0.01,8.32E-01
myofibril assembly (GO:0030239),2,0,0.37,-, < 0.01,6.92E-01
actomyosin contractile ring assembly (GO:0000915),1,0,0.18,-, < 0.01,8.32E-01
assembly of actomyosin apparatus involved in cytokinesis (GO:0000912),1,0,0.18,-, < 0.01,8.32E-01
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),2,0,0.37,-, < 0.01,6.92E-01
execution phase of apoptosis (GO:0097194),8,0,1.47,-, < 0.01,2.30E-01
vesicle-mediated transport in synapse (GO:0099003),13,0,2.39,-, < 0.01,9.15E-02
"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",10,0,1.84,-, < 0.01,1.59E-01
cytoplasmic translational initiation (GO:0002183),4,0,0.74,-, < 0.01,4.79E-01
cellular response to lipid (GO:0071396),1,0,0.18,-, < 0.01,8.32E-01
regulation of protein stability (GO:0031647),5,0,0.92,-, < 0.01,3.99E-01
cellular response to steroid hormone stimulus (GO:0071383),1,0,0.18,-, < 0.01,8.32E-01
cellular copper ion homeostasis (GO:0006878),1,0,0.18,-, < 0.01,8.32E-01
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),5,0,0.92,-, < 0.01,3.99E-01
regulation of cell junction assembly (GO:1901888),3,0,0.55,-, < 0.01,5.76E-01
protein monoubiquitination (GO:0006513),5,0,0.92,-, < 0.01,3.99E-01
mitotic DNA replication (GO:1902969),7,0,1.29,-, < 0.01,2.76E-01
axonemal dynein complex assembly (GO:0070286),2,0,0.37,-, < 0.01,6.92E-01
regulation of G1/S transition of mitotic cell cycle (GO:2000045),5,0,0.92,-, < 0.01,3.99E-01
nucleotide transport (GO:0006862),1,0,0.18,-, < 0.01,8.32E-01
cellular response to growth factor stimulus (GO:0071363),16,0,2.94,-, < 0.01,5.26E-02
mitochondrial calcium ion transmembrane transport (GO:0006851),1,0,0.18,-, < 0.01,8.32E-01
meiotic sister chromatid segregation (GO:0045144),3,0,0.55,-, < 0.01,5.76E-01
homologous chromosome segregation (GO:0045143),2,0,0.37,-, < 0.01,6.92E-01
regulation of system process (GO:0044057),1,0,0.18,-, < 0.01,8.32E-01
negative regulation of BMP signaling pathway (GO:0030514),2,0,0.37,-, < 0.01,6.92E-01
regulation of BMP signaling pathway (GO:0030510),3,0,0.55,-, < 0.01,5.76E-01
negative regulation of Ras protein signal transduction (GO:0046580),1,0,0.18,-, < 0.01,8.32E-01
outer dynein arm assembly (GO:0036158),2,0,0.37,-, < 0.01,6.92E-01
BMP signaling pathway (GO:0030509),11,0,2.02,-, < 0.01,1.32E-01
iron ion transport (GO:0006826),5,0,0.92,-, < 0.01,3.99E-01
epithelial cell differentiation (GO:0030855),2,0,0.37,-, < 0.01,6.92E-01
cardiac muscle tissue development (GO:0048738),1,0,0.18,-, < 0.01,8.32E-01
gland development (GO:0048732),1,0,0.18,-, < 0.01,8.32E-01
negative regulation of chromatin silencing (GO:0031936),1,0,0.18,-, < 0.01,8.32E-01
striated muscle tissue development (GO:0014706),1,0,0.18,-, < 0.01,8.32E-01
regulation of chromatin silencing (GO:0031935),3,0,0.55,-, < 0.01,5.76E-01
deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),3,0,0.55,-, < 0.01,5.76E-01
protein localization to cytoskeleton (GO:0044380),2,0,0.37,-, < 0.01,6.92E-01
